
<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:art="http://www.rsc.org/schema/rscart38" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rsc="urn:rsc.org" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-5HVSFVCN');</script><!--End Google Tag Manager--><title>Oxidative cross-dehydrogenative coupling (CDC) via C (sp2) –H bond functionalization: tert -butyl peroxybenzoate (TBPB)-promoted regioselective direct ...  - RSC Advances (RSC Publishing) DOI:10.1039/D1RA02225C</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2021/ra/d1ra02225c"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":0,"applicationTime":79,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(31),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(32),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),S=t(15),P=t(10),M=t("ee"),C=M.get("tracer"),N=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),P.on(p,r),M.on(d,o),b.on(l,o),P.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),S.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,N(!0)),w[v]("load",i,N(!0)),w[v]("popstate",function(){i(0,U>1)},N(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(32),a=t(31);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(31),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(28),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);return e.protocol&&"data"===e.protocol?void g("Ajax/DataUrl/Excluded"):void(e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this)))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=t(25).recordSupportability,y=NREUM.o.REQ,x=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof x&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;if("string"==typeof i?n=i:"object"==typeof i&&i instanceof y?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n),"data"!==this.params.protocol){var s=(""+(i&&i instanceof y&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}}),u.on("fetch-done",function(t,e){if(this.endTime=a.now(),this.params||(this.params={}),"data"===this.params.protocol)return void g("Ajax/DataUrl/Excluded");this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];if(0===(t||"").indexOf("data:"))return{protocol:"data"};var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(31),s=t(32),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(33);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?l("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&l("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(f&&f<r.startTime)return;var o=[r],i=a({});i&&o.push(i),l("lcp",o)}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||l("cls",[t])})}function a(t){var e=navigator.connection||navigator.mozConnection||navigator.webkitConnection;if(e)return e.type&&(t["net-type"]=e.type),e.effectiveType&&(t["net-etype"]=e.effectiveType),e.rtt&&(t["net-rtt"]=e.rtt),e.downlink&&(t["net-dlink"]=e.downlink),t}function s(t){if(t instanceof w&&!y){var e=Math.round(t.timeStamp),n={type:t.type};a(n),e<=h.now()?n.fid=h.now()-e:e>h.offset&&e<=Date.now()?(e-=h.offset,n.fid=h.now()-e):e=h.now(),y=!0,l("timing",["fi",e,n])}}function c(t){"hidden"===t&&(f=h.now(),l("pageHide",[f]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var f,u,d,p,l=t("handle"),h=t("loader"),m=t(30),v=t(23),w=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){u=new PerformanceObserver(r);try{u.observe({entryTypes:["paint"]})}catch(g){}d=new PerformanceObserver(o);try{d.observe({entryTypes:["largest-contentful-paint"]})}catch(g){}p=new PerformanceObserver(i);try{p.observe({type:"layout-shift",buffered:!0})}catch(g){}}if("addEventListener"in document){var y=!1,x=["click","keydown","mousedown","pointerdown","touchstart"];x.forEach(function(t){document.addEventListener(t,s,v(!1))})}m(c)}},{}],28:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(t)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],29:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],30:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],31:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],32:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],33:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(31),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!T++){var t=O.info=NREUM.info,e=m.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(E,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+O.offset],null,"api"),s("timing",["load",n]);var r=m.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=l+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===m.readyState&&i()}function i(){s("mark",["domContent",a()+O.offset],null,"api")}var a=t(26),s=t("handle"),c=t(31),f=t("ee"),u=t(29),d=t(21),p=t(23),l=d.getConfiguration("ssl")===!1?"http":"https",h=window,m=h.document,v="addEventListener",w="attachEvent",g=h.XMLHttpRequest,y=g&&g.prototype,x=!1;NREUM.o={ST:setTimeout,SI:h.setImmediate,CT:clearTimeout,XHR:g,REQ:h.Request,EV:h.Event,PR:h.Promise,MO:h.MutationObserver};var b=""+location,E={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1216.min.js"},R=g&&y&&y[v]&&!/CriOS/.test(navigator.userAgent),O=e.exports={offset:a.getLastTimestamp(),now:a,origin:b,features:{},xhrWrappable:R,userAgent:u,disabled:x};if(!x){t(20),t(27),m[v]?(m[v]("DOMContentLoaded",i,p(!1)),h[v]("load",r,p(!1))):(m[w]("onreadystatechange",o),h[w]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var T=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(32),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Richa Sharma"/><meta name="DC.Creator" content="Lalit Yadav"/><meta name="DC.Creator" content="Ravi Kant Yadav"/><meta name="DC.Creator" content="Sandeep Chaudhary"/><meta name="DC.title" content="Oxidative cross-dehydrogenative coupling (CDC) via C (sp2) –H bond functionalization: tert -butyl peroxybenzoate (TBPB)-promoted regioselective direct C-3 acylation/benzoylation of 2 H -indazoles with aldehydes/benzyl alcohols/styrenes  "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2021/04/15"/><meta name="DC.Identifier" scheme="doi" content="10.1039/D1RA02225C"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Oxidative cross-dehydrogenative coupling (CDC) via C (sp2) –H bond functionalization: tert -butyl peroxybenzoate (TBPB)-promoted regioselective direct C-3 acylation/benzoylation of 2 H -indazoles with aldehydes/benzyl alcohols/styrenes  "/><meta name="citation_author" content="Richa Sharma"/><meta name="citation_author" content="Lalit Yadav"/><meta name="citation_author" content="Ravi Kant Yadav"/><meta name="citation_author" content="Sandeep Chaudhary"/><meta name="citation_online_date" content="2021/04/15"/><meta name="citation_date" content="2021"/><meta name="citation_journal_title" content="RSC Advances"/><meta name="citation_volume" content="11"/><meta name="citation_issue" content="23"/><meta name="citation_firstpage" content="14178"/><meta name="citation_lastpage" content="14192"/><meta name="citation_doi" content="10.1039/D1RA02225C"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2021/ra/d1ra02225c"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2021/ra/d1ra02225c"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2021/ra/d1ra02225c"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5HVSFVCN" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2021/ra/d1ra02225c">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:d0ra08474c)" href="/en/content/articlehtml/2021/ra/d0ra08474c" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:d1ra01039e)" href="/en/content/articlehtml/2021/ra/d1ra01039e" target="_BLANK">Next Article</a></span></div><div class="right_head"><div id="crossmark_container"><div id="crossmark-content"><a id="open-crossmark" href="#" data-target="crossmark"><img style="max-width:100px" id="crossmark-logo" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg" alt="Check for updates"/></a><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"> </script></div></div><br/><span class="oa"><img src="/content/newimages/open_access_blue.png" alt=""/> Open Access Article<br/><img src="/content/newimages/CCBY-NC.svg" alt=""/>
This Open Access Article is licensed under a <a rel="license" href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution-Non Commercial 3.0 Unported Licence</a></span></div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/D1RA02225C">10.1039/D1RA02225C</a>
(Paper)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/2046-2069/2011">RSC Adv.</a></span>, 2021, <strong>11</strong>, 14178-14192</div><h1 id="sect271"><span class="title_heading">Oxidative cross-dehydrogenative coupling (CDC) <span class="italic">via</span> C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–H bond functionalization: <span class="italic">tert</span>-butyl peroxybenzoate (TBPB)-promoted regioselective direct C-3 acylation/benzoylation of 2<span class="italic">H</span>-indazoles with aldehydes/benzyl alcohols/styrenes<a title="Select to navigate to footnote" href="#fn1">†</a></span></h1><p class="header_text">
<span class="bold">Richa Sharma</span>, 
<span class="bold">Lalit Yadav</span>, 
<span class="bold">Ravi Kant Yadav</span><span class="bold"> and </span>
<span class="bold">Sandeep Chaudhary</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Sandeep Chaudhary (orcid.org/0000-0002-1444-3895) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0002-1444-3895"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*
<br/><span class="italic">Laboratory of Organic and Medicinal Chemistry (OMC Lab), Department of Chemistry, Malaviya National Institute of Technology, Jawaharlal Nehru Marg, Jaipur-302017, India. E-mail: <a href="mailto:schaudhary.chy@mnit.ac.in">schaudhary.chy@mnit.ac.in</a>;  Fax: +911412529029;   Tel: +911412713319</span>
</p><div id="art-admin"><span class="italic bold">Received 
20th March 2021
</span><span class="bold italic">, Accepted 26th March 2021</span></div><p class="bold italic">First published on 15th April 2021</p><hr/><div class="abstract"><h2>Abstract</h2><p>An efficient, cost-effective, transition-metal-free, oxidative C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–H/C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–H cross-dehydrogenative coupling <span class="italic">via</span> a C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–H bond functionalization protocol for the regioselective direct C-3 acylation/benzoylation of substituted 2<span class="italic">H</span>-Indazoles <strong>1a–m</strong> with substituted aldehydes <strong>2a–q</strong>/benzyl alcohols <strong>5a–e</strong>/styrenes <strong>6a–e</strong> is reported. The operationally simple protocol proceeds in the presence of <span class="italic">tert</span>-butyl peroxybenzoate (TBPB) as an oxidant in chlorobenzene (PhCl) as a solvent at 110 °C for 24 h under an inert atmosphere, which furnished a diverse variety of substituted 3-(acyl/benzoyl)-2<span class="italic">H</span>-indazoles <strong>3a–q</strong>/<strong>4a–l</strong> in up to 87% yields. The reaction involves a free-radical mechanism and proceeds <span class="italic">via</span> the addition of an <span class="italic">in situ</span> generated acyl radical (from aldehydes/benzyl alcohols/styrenes) on 2<span class="italic">H</span>-indazoles. The functional group tolerance, broad substrate scope, control/competitive experiments and gram-scale synthesis and its application to the synthesis of anti-inflammatory agent 11 and novel indazole-fused diazepine 13 further signify the versatile nature of the developed methodology.</p></div><hr/>
<h2 id="sect349"><span class="a_heading">Introduction</span></h2>
<span>During the last two decades, oxidative cross-dehydrogenative coupling, often abbreviated to “oxidative CDC reaction”, between two C–H bonds has been recognized as a greener fundamental synthetic approach in C–C bond forming reactions due to its association with several advantages such as being metal-free, high yields, cost effectiveness, operational simplicity, high selectivity, step-/atom-economy, product selectivity, no pre-functionalization of starting materials, reduced waste, energy and resource competence, <span class="italic">etc.</span><a title="Select to navigate to references" href="#cit1"><sup><span class="sup_ref">1</span></sup></a> Indazoles are renowned bioactive heterocyclic scaffolds which are found abundantly in several pharmaceutically privileged bioactive natural products/therapeutics/drugs molecules<a title="Select to navigate to references" href="#cit2"><sup><span class="sup_ref">2</span></sup></a> and are bestowed with a wide array of biological activities such as antimicrobial, anticancer, antitumor, HIV-protease inhibition, antiplatelet, anti-depressant, and anti-inflammatory actions.<a title="Select to navigate to references" href="#cit3"><sup><span class="sup_ref">3</span></sup></a></span>
<p class="otherpara">Indazole functionalization has achieved emerging demand in the fields of organic and medicinal chemistry as the functionalization of indazoles can be rendered into advantageous structural motifs for various medications.<a title="Select to navigate to references" href="#cit4"><sup><span class="sup_ref">4</span></sup></a> Therefore, the development of a new synthetic pathway to introduce various functional groups on 2<span class="italic">H</span>-indazoles leading to an increase in the molecular abundance and the formation of new bioactive molecules, will always be of the utmost importance to medicinal chemistry and drug discovery.</p>
<p class="otherpara">In particular, acylated 2<span class="italic">H</span>-indazoles have received tremendous attention as a pharmaceutically important class of structural motifs in a large number of bioactive skeletons/therapeutic molecules. Noticeably, C3-acylated-(2<span class="italic">H</span>)-indazoles <strong>I–V</strong> are endowed with several biological activities, such as antiemetic and anti-inflammatory properties (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>).<a title="Select to navigate to references" href="#cit5"><sup><span class="sup_ref">5</span></sup></a> Therefore, the development of a direct synthetic strategy <span class="italic">via</span> an oxidative cross-dehydrogenative coupling pathway for the C-3 acylation of 2<span class="italic">H</span>-indazoles is a highly desirable and challenging area of investigation. It becomes more appealing if it proceeds through a transition-metal-free approach. A few transition-metal-catalyzed (Ag, Ni) synthetic approaches <span class="italic">via</span> C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–H bond activation/functionalization have been reported for the direct, regioselective, C-3 acylation of (2<span class="italic">H</span>)-indazoles with either Ag-catalyzed decarboxylative cross-coupling of α-keto acids<a title="Select to navigate to references" href="#cit6"><sup><span class="sup_ref">6</span></sup></a> or with an Ni-catalyzed reaction on substituted aldehydes<a title="Select to navigate to references" href="#cit7"><sup><span class="sup_ref">7</span></sup></a> and with an Ag-catalyzed reaction with substituted Hantzsch esters as acyl radical sources<a title="Select to navigate to references" href="#cit8"><sup><span class="sup_ref">8</span></sup></a> (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1</a>). However, these strategies are associated with several drawbacks such as the use of costly metals, the use of additives/ligands, and limited substrate scope. In addition, the separate synthesis of an acylation/benzoylation source further amplifies its limitations and increases the tediousness of these methodologies. However, there has been no report of the direct C-3 acylation of 2-aryl-2<span class="italic">H</span>-indazoles with metal-free and ligand-/additive-free catalysis.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><a href="/image/article/2021/RA/d1ra02225c/d1ra02225c-f1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1ra02225c-f1.tif" src="/image/article/2021/RA/d1ra02225c/d1ra02225c-f1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title">Representative examples of various bioactive molecules/drugs/therapeutics with a 2<span class="italic">H</span>-indazole moiety.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch1"><a href="/image/article/2021/RA/d1ra02225c/d1ra02225c-s1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1ra02225c-s1.tif" src="/image/article/2021/RA/d1ra02225c/d1ra02225c-s1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 1 </b> <span id="sch1"><span class="graphic_title">Previous methodologies and present work: TBPB-promoted approach to regioselective direct C-3 acylation/benzoylation of 2-aryl-2<span class="italic">H</span>-indazoles with substituted aldehydes/benzyl alcohols/styrenes.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">Herein, we report a cost-effective, highly efficient, <span class="italic">tert</span>-butyl peroxybenzoate (TBPB)-promoted, regioselective, direct C-3 acylation/benzoylation of 2-aryl-2<span class="italic">H</span>-indazoles <strong>1a–m</strong> with different aldehydes <strong>2a–q</strong>/benzyl alcohols <strong>5a–e</strong>/styrenes <strong>6a–e</strong> <span class="italic">via</span> C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–H/C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–H cross-dehydrogenative coupling at 110 °C for 24 h under N<small><sub>2</sub></small> atmosphere which furnished 3-(acylated/benzoylated)-2-aryl-2<span class="italic">H</span>–indazoles <strong>3a–q</strong>/<strong>4a–l</strong> in excellent (87%) yields, with a broad range of functional group tolerances and varied substrate compatibilities [<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1</a>]. Succinctly, this is the first detailed investigation of an oxidant-promoted C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–H/C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–H cross-dehydrogenative coupling method for the regioselective direct C-3 acylation/benzoylation of 2-aryl-2<span class="italic">H</span>-indazoles.</p>

<h2 id="sect404"><span class="a_heading">Results and discussion</span></h2>
<span>We initiated our optimization study by investigating direct C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–C<small><sub>(sp<small><sup>2</sup></small>)</sub></small> coupling by taking 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> and 4-methylbenzaldehyde <strong>2a</strong> as the starting substrate (<a title="Select to navigate to table" href="#tab1">Table 1</a>).</span>

<div class="table_caption"><b>Table 1</b> <span id="tab1">Optimization study<i><small><sup style="color: red;"><a title="" href="#tab1fna">a</a></sup></small></i></span>
		</div>

<div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col/><col/><col/><col/><col/><col/></colgroup>






<thead align="left">
<tr align="left" valign="bottom">
<th colspan="6" align="left" valign="bottom" class="border_black"><p align="center"><a href="/image/article/2021/RA/d1ra02225c/d1ra02225c-u1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1ra02225c-u1.tif" src="/image/article/2021/RA/d1ra02225c/d1ra02225c-u1.gif"/></a></p></th>
</tr>
<tr align="left" valign="bottom">
<th align="left" valign="bottom" class="border_black">S. no.</th>
<th align="left" valign="bottom" class="border_black">Oxidant (2.5 equiv.)</th>
<th align="left" valign="bottom" class="border_black">Catalyst (20 mol%)</th>
<th align="left" valign="bottom" class="border_black">Solvent</th>
<th align="left" valign="bottom" class="border_black">Temp. (°C)</th>
<th align="left" valign="bottom" class="border_black">Yield (%)</th>
</tr>
</thead>
<tfoot align="left">
<tr align="left">
<th colspan="6"><a id="tab1fna"><span class="tfootnote">a</span></a> <span class="sup_inf">Reaction conditions: 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (0.13 mmol), 4-methyl benzaldehyde <strong>2a</strong> (0.27 mmol), oxidant (0.33 mmol), catalyst (20 mol%), N<small><sub>2</sub></small> atm, 110 °C, 24 h.</span><a id="tab1fnb"><span class="tfootnote">b</span></a> <span class="sup_inf">For details, see ref. <a title="Select to navigate to references" href="#cit9f">9<span class="italic">f</span></a>.</span><a id="tab1fnc"><span class="tfootnote">c</span></a> <span class="sup_inf">TBHP (0.53 mmol) and NCS (30 mol%) were used.</span><a id="tab1fnd"><span class="tfootnote">d</span></a> <span class="sup_inf">TFA (0.6 equiv.) was used.</span><a id="tab1fne"><span class="tfootnote">e</span></a> <span class="sup_inf"><strong>2a</strong> (1 equiv.) was used.</span><a id="tab1fnf"><span class="tfootnote">f</span></a> <span class="sup_inf">Reaction was allowed to run for 16 h.</span></th>
</tr>
</tfoot>
<tbody align="left">
<tr align="left">
<td valign="top">1</td>
<td valign="top">TBHP<i><small><sup style="color: red;"><a title="" href="#tab1fnb">b</a></sup></small></i></td>
<td valign="top">NCS</td>
<td valign="top">DCE</td>
<td valign="top">110</td>
<td valign="top">NR<i><small><sup style="color: red;"><a title="" href="#tab1fnc">c</a></sup></small></i></td>
</tr>
<tr align="left">
<td valign="top">2</td>
<td valign="top">TBHP</td>
<td valign="top">NCS</td>
<td valign="top">DCE</td>
<td valign="top">110</td>
<td valign="top">30</td>
</tr>
<tr align="left">
<td valign="top">3</td>
<td valign="top">TBHP</td>
<td valign="top">TFA</td>
<td valign="top">DCE</td>
<td valign="top">110</td>
<td valign="top">40<i><small><sup style="color: red;"><a title="" href="#tab1fnd">d</a></sup></small></i></td>
</tr>
<tr align="left">
<td valign="top">4</td>
<td valign="top">TBHP</td>
<td valign="top">TBAI</td>
<td valign="top">DCE</td>
<td valign="top">110</td>
<td valign="top">NR</td>
</tr>
<tr align="left">
<td valign="top">5</td>
<td valign="top">TBHP</td>
<td valign="top">NaI</td>
<td valign="top">—</td>
<td valign="top">110</td>
<td valign="top">NR</td>
</tr>
<tr align="left">
<td valign="top">6</td>
<td valign="top">TBHP</td>
<td valign="top">KI</td>
<td valign="top">DCE</td>
<td valign="top">110</td>
<td valign="top">NR</td>
</tr>
<tr align="left">
<td valign="top">7</td>
<td valign="top">TBHP</td>
<td valign="top">I<small><sub>2</sub></small></td>
<td valign="top">DCE</td>
<td valign="top">110</td>
<td valign="top">NR</td>
</tr>
<tr align="left">
<td valign="top">8</td>
<td valign="top">TBHP</td>
<td valign="top">—</td>
<td valign="top">DCE</td>
<td valign="top">110</td>
<td valign="top">65</td>
</tr>
<tr align="left">
<td valign="top">9</td>
<td valign="top">TBHP</td>
<td valign="top">—</td>
<td valign="top">DCE</td>
<td valign="top">110</td>
<td valign="top">10<i><small><sup style="color: red;"><a title="" href="#tab1fne">e</a></sup></small></i></td>
</tr>
<tr align="left">
<td valign="top">10</td>
<td valign="top">TBHP</td>
<td valign="top">—</td>
<td valign="top">PhCl</td>
<td valign="top">110</td>
<td valign="top">68</td>
</tr>
<tr align="left">
<td valign="top">11</td>
<td valign="top">DTBP</td>
<td valign="top">—</td>
<td valign="top">PhCl</td>
<td valign="top">110</td>
<td valign="top">70</td>
</tr>
<tr align="left">
<td valign="top"><span class="bold">12</span></td>
<td valign="top"><span class="bold">TBPB</span></td>
<td valign="top"><span class="bold">—</span></td>
<td valign="top"><span class="bold">PhCl</span></td>
<td valign="top"><span class="bold">110</span></td>
<td valign="top"><span class="bold">82</span></td>
</tr>
<tr align="left">
<td valign="top">13</td>
<td valign="top">DCP</td>
<td valign="top">—</td>
<td valign="top">PhCl</td>
<td valign="top">110</td>
<td valign="top">51</td>
</tr>
<tr align="left">
<td valign="top">14</td>
<td valign="top">Lauroyl peroxide</td>
<td valign="top">—</td>
<td valign="top">PhCl</td>
<td valign="top">110</td>
<td valign="top">18</td>
</tr>
<tr align="left">
<td valign="top">15</td>
<td valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
<td valign="top">—</td>
<td valign="top">PhCl</td>
<td valign="top">110</td>
<td valign="top">NR</td>
</tr>
<tr align="left">
<td valign="top">16</td>
<td valign="top">Cumene hydroperoxide</td>
<td valign="top">—</td>
<td valign="top">PhCl</td>
<td valign="top">110</td>
<td valign="top">Trace</td>
</tr>
<tr align="left">
<td valign="top">17</td>
<td valign="top">K<small><sub>2</sub></small>S<small><sub>2</sub></small>O<small><sub>8</sub></small></td>
<td valign="top">—</td>
<td valign="top">PhCl</td>
<td valign="top">110</td>
<td valign="top">NR</td>
</tr>
<tr align="left">
<td valign="top">18</td>
<td valign="top">Oxone</td>
<td valign="top">—</td>
<td valign="top">PhCl</td>
<td valign="top">110</td>
<td valign="top">NR</td>
</tr>
<tr align="left">
<td valign="top">19</td>
<td valign="top">(NH<small><sub>4</sub></small>)<small><sub>2</sub></small>S<small><sub>2</sub></small>O<small><sub>8</sub></small></td>
<td valign="top">—</td>
<td valign="top">PhCl</td>
<td valign="top">110</td>
<td valign="top">NR</td>
</tr>
<tr align="left">
<td valign="top">20</td>
<td valign="top">PIDA</td>
<td valign="top">—</td>
<td valign="top">PhCl</td>
<td valign="top">110</td>
<td valign="top">Trace</td>
</tr>
<tr align="left">
<td valign="top">21</td>
<td valign="top">O<small><sub>2</sub></small></td>
<td valign="top">—</td>
<td valign="top">PhCl</td>
<td valign="top">110</td>
<td valign="top">NR</td>
</tr>
<tr align="left">
<td valign="top">22</td>
<td valign="top">TBPB</td>
<td valign="top">—</td>
<td valign="top">ACN</td>
<td valign="top">110</td>
<td valign="top">71</td>
</tr>
<tr align="left">
<td valign="top">23</td>
<td valign="top">TBPB</td>
<td valign="top">—</td>
<td valign="top">Toluene</td>
<td valign="top">110</td>
<td valign="top">70</td>
</tr>
<tr align="left">
<td valign="top">24</td>
<td valign="top">TBPB</td>
<td valign="top">—</td>
<td valign="top">DMSO</td>
<td valign="top">110</td>
<td valign="top">18</td>
</tr>
<tr align="left">
<td valign="top">25</td>
<td valign="top">TBPB</td>
<td valign="top">—</td>
<td valign="top">Dioxane</td>
<td valign="top">110</td>
<td valign="top">15</td>
</tr>
<tr align="left">
<td valign="top">26</td>
<td valign="top">TBPB</td>
<td valign="top">—</td>
<td valign="top">DMF</td>
<td valign="top">110</td>
<td valign="top">Trace</td>
</tr>
<tr align="left">
<td valign="top">27</td>
<td valign="top">TBPB</td>
<td valign="top">—</td>
<td valign="top">THF</td>
<td valign="top">110</td>
<td valign="top">Trace</td>
</tr>
<tr align="left">
<td valign="top">28</td>
<td valign="top">TBPB</td>
<td valign="top">—</td>
<td valign="top">H<small><sub>2</sub></small>O</td>
<td valign="top">110</td>
<td valign="top">Trace</td>
</tr>
<tr align="left">
<td valign="top">29</td>
<td valign="top">TBPB</td>
<td valign="top">—</td>
<td valign="top">AcOH</td>
<td valign="top">110</td>
<td valign="top">Trace</td>
</tr>
<tr align="left">
<td valign="top">30</td>
<td valign="top">TBHP</td>
<td valign="top">—</td>
<td valign="top">TFA</td>
<td valign="top">110</td>
<td valign="top">NR</td>
</tr>
<tr align="left">
<td valign="top">31</td>
<td valign="top">TBPB</td>
<td valign="top">—</td>
<td valign="top">PhCl</td>
<td valign="top">80</td>
<td valign="top">72</td>
</tr>
<tr align="left">
<td valign="top">32</td>
<td valign="top">TBPB</td>
<td valign="top">—</td>
<td valign="top">PhCl</td>
<td valign="top">140</td>
<td valign="top">68</td>
</tr>
<tr align="left">
<td valign="top">33</td>
<td valign="top">TBPB</td>
<td valign="top">—</td>
<td valign="top">PhCl</td>
<td valign="top">110</td>
<td valign="top">71<i><small><sup style="color: red;"><a title="" href="#tab1fnf">f</a></sup></small></i></td>
</tr>
</tbody>
</table></div></div>
<hr class="hrule"/><br/>
<p class="otherpara">It has been noted that TBHP, either alone or in combination, has been utilized in several oxidative cross-dehydrogenative coupling reactions;<a title="Select to navigate to references" href="#cit9"><sup><span class="sup_ref">9</span></sup></a> we had chosen <span class="italic">tert</span>-butyl hydroperoxide (TBHP) as an oxidant and <span class="italic">N</span>-chlorosuccinimide (NCS) as a catalyst for the beginning of our study. Therefore, using the procedure in the literature,<a title="Select to navigate to references" href="#cit9f"><sup><span class="sup_ref">9f</span></sup></a> we carried out a reaction of <strong>1a</strong> with <strong>2a</strong> in the presence of TBHP (0.53 mmol, 4 equiv.) and NCS (30 mol%) in dichloroethane (DCE) at 110 °C for 24 h under an inert atmosphere. However, the desired product <strong>3a</strong> was not found at all and several spots appeared on TLC (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entry 1). Then, keeping all other reaction parameters the same, we carried out the same reaction as shown in entry no. 1 with reduced equivalents of both TBHP and NCS catalyst. Intriguingly, <strong>3a</strong> was obtained, albeit in low (30%) yield (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entry 2). Subsequently, we examined the screening of some other well-known reagents which had previously been utilized extensively in CDC reactions (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entries 3–7). While the reaction performed in TFA furnished <strong>3a</strong> in 40% yield, iodine-based catalysts were found ineffective in improving the yield of the reaction. Furthermore, keeping all the reaction conditions the same, the reaction was performed without a catalyst, which furnished <strong>3a</strong> in 65% yield (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entry 8). This observation instructed us to stop further use of any additives as a catalyst. However, the reaction performed with less equivalents of <strong>2a</strong> (1 equiv.) drastically reduced the yield of <strong>3a</strong> (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entry 9). It has been reported in the literature that chlorobenzene has been utilized as an effective solvent for cross-dehydrogenative coupling reactions.<a title="Select to navigate to references" href="#cit10"><sup><span class="sup_ref">10</span></sup></a> Therefore, we conducted the same reaction in chlorobenzene instead of DCE and <strong>3a</strong> was obtained in 68% yield (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entry 10).</p>
<p class="otherpara">Then, we carried out the screening of several organic as well as inorganic oxidants, such as di-<span class="italic">tert</span>-butyl peroxide (DTBP), <span class="italic">tert</span>-butyl peroxybenzoate (TBPB), dicumyl peroxide (DCP), lauroyl peroxide, H<small><sub>2</sub></small>O<small><sub>2</sub></small>, cumene hydroperoxide, K<small><sub>2</sub></small>S<small><sub>2</sub></small>O<small><sub>8</sub></small>, oxone, (NH<small><sub>4</sub></small>)<small><sub>2</sub></small>S<small><sub>2</sub></small>O<small><sub>8</sub></small>, (diacetoxyiodo)benzene (PIDA), and oxygen gas, while keeping all the other reaction parameters the same (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entries 11–21). It was found that while DTBP, TBPB and DCP furnished <strong>3a</strong> in 70%, 82% and 51% yields, respectively; the reaction performed using lauroyl peroxide gave <strong>3a</strong> in only 18% yield (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entries 11–14). The rest of the oxidants either did not furnish <strong>3a</strong> at all or afforded <strong>3a</strong> in only trace amounts (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entries 15–21).</p>
<p class="otherpara">Sequentially, the screening of several polar/non-polar solvents was also carried out (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entries 22–30). It should be noted that none of the solvents were found to be effective except for chlorobenzene. Afterwards, keeping all reaction parameters the same, the effect of variation in temperature and time was studied. It was observed that increasing or decreasing the temperature and time did not have a beneficial effect on the yield of the reaction (<a title="Select to navigate to table" href="#tab1">Table 1</a>, entries 31–33). Thus, overall, <span class="italic">2 equivalents of substituted aldehydes, 2.5 equivalents of tert-butyl peroxybenzoate (TBPB) dissolved in chlorobenzene as solvent at 110 °C for 24 h under N</span><small><sub><span class="italic">2</span></sub></small> <span class="italic">atmosphere</span> were found to be the best optimization reaction conditions for the direct C-3 acylation/benzoylation of 2-aryl-2<span class="italic">H</span>-indazoles <span class="italic">via</span> a C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–H/C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–H cross-dehydrogenative coupling methodology.</p>
<p class="otherpara">Taking 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> as a starting substrate, several substituted aromatic/aliphatic/hetero-aromatic aldehydes <strong>2a–q</strong> were reacted under the optimized reaction conditions, which furnished substituted 3-(acylated/benzoylated)-2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazoles <strong>3a–q</strong> in 57–86% yield (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>). Like <strong>3a</strong>, <strong>1a</strong> was reacted with benzaldehyde <strong>2b</strong> under the optimized reaction conditions and furnished <strong>3b</strong> in 80% yield. It has been noted that aromatic aldehydes with electron-donating groups (EDGs) at the <span class="italic">p</span>-position were found to be well-tolerated and afforded the corresponding C-3 benzoylated-2<span class="italic">H</span>-indazoles <strong>3a</strong> and <strong>3c</strong> in 82% and 86% yields, respectively. However, aromatic aldehyde <strong>2d</strong> with two EDG (<span class="italic">i.e.</span>, OCH<small><sub>3</sub></small>) groups was subjected to reaction with <strong>1a</strong> under the optimized conditions; <strong>3d</strong> was afforded in slightly lower (78%) yield compared to <strong>3a</strong> and <strong>3c</strong>. This could be due to the steric hindrance created by the OCH<small><sub>3</sub></small> group at the <span class="italic">o</span>-position to the aldehydic functionality. In the case of aromatic aldehydes containing a halo (X = F, Cl, Br) group at the <span class="italic">para</span>-position, the reaction of <strong>1a</strong> with <strong>2e–g</strong> under optimized conditions furnished <strong>3e–g</strong> in 81–84% yield. However, keeping all the reaction conditions the same, a decrease in the reactivity of aromatic aldehydes containing halo groups at the <span class="italic">meta</span>-/<span class="italic">ortho</span>-positions, was observed and <strong>3h</strong> and <strong>3i</strong> were obtained in 67% and 58% yields, respectively. In addition, the aromatic aldehyde containing an electron-withdrawing group (EWG) <strong>2p</strong> was found to be totally reluctant to undergo the optimized reaction conditions. Similarly, phenyl acetaldehyde <strong>2q</strong> was also found to be unreactive. Furthermore, in order to check the versatility of the methodology, a few aliphatic aldehydes <strong>2j–k</strong> were reacted with <strong>1a</strong> under the optimized reaction conditions and afforded <strong>3j</strong> and <strong>3k</strong> in 68% and 61% yields, respectively. Comparing aromatic aldehydes with aliphatic aldehydes, the latter were found to be less reactive than the former. A different observation was noticed in the current protocol when the number of carbon atoms increased to four (unbranched and/or branched) in the aldehydes.<a title="Select to navigate to references" href="#cit7"><sup><span class="sup_ref">7</span></sup></a> Compounds <strong>2l–m</strong> on reaction with <strong>1a</strong> under the optimized reaction conditions did not furnish C-3 acylated 2<span class="italic">H</span>-indazoles but incorporated the corresponding alkyl group of the <strong>2l</strong> and <strong>2m</strong> <span class="italic">via</span> decarbonylation and furnished <strong>3l</strong> and <strong>3m</strong> in 60% and 71% yields, respectively. We could speculate on the stability of the corresponding generated free-radicals on treatment with TBPB based on the greater +I effect of the propyl group (generated after decarbonylation of <span class="italic">n</span>-butyraldehyde) compared to the +I effect of the ethyl group (generated after decarbonylation of <span class="italic">n</span>-propionaldehyde). This could lead to the formation of unprecedented <strong>3l</strong> from <strong>2l</strong> in 60% yield. Furthermore, the instability of the acyl radical formed from <strong>2m</strong> on treatment with TBPB can be understood by the formation of a more stable secondary free-radical of isobutyraldehyde (generated after decarbonylation of <span class="italic">n</span>-isobutyraldehyde).<a title="Select to navigate to reference" href="#cit6"><sup><span class="sup_ref">6,7</span></sup></a> Later on, the generated alkyl free-radical attacks at the C-3 position of 2-aryl-2<span class="italic">H</span>-indazole, subsequently leading to the formation of C-3-alkylated-2-aryl-2<span class="italic">H</span>-indazoles.<a title="Select to navigate to reference" href="#cit6"><sup><span class="sup_ref">6,7</span></sup></a> Our protocol was also found to be feasible with hetero-aromatic aldehydes. Significantly, good yields were observed when pyrrole-2-carboxaldehyde <strong>2n</strong>, furan-2-carboxaldehyde <strong>2o</strong>, 5-methyl-furan-2-carboxaldehyde <strong>2p</strong> and 5-bromothiophene-2-carboxaldehyde <strong>2q</strong> were reacted under the optimized reaction conditions to furnish <strong>3n–q</strong>.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch2"><a href="/image/article/2021/RA/d1ra02225c/d1ra02225c-s2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1ra02225c-s2.tif" src="/image/article/2021/RA/d1ra02225c/d1ra02225c-s2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 2 </b> <span id="sch2"><span class="graphic_title">Substrate scope: reaction of 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> with various aldehydes <strong>2a–q</strong> for the synthesis of substituted 3-acylated 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazoles <strong>3a–q</strong><small><sup>a,b</sup></small>. <small><sup>a</sup></small>Reaction conditions: 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (0.5 mmol), substituted aldehydes <strong>2a–q</strong> (1.0 mmol), oxidant (1.25 mmol), PhCl, N<small><sub>2</sub></small> atm, 110 °C, 24 h. <small><sup>b</sup></small>Isolated yield.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">Overall, the reactivity order for different types of aldehydes has been depicted as:<br/><table><tr><td class="eqnText">Aromatic &gt; aliphatic &gt; hetero-aromatic</td></tr></table></p>
<p class="otherpara">On the other hand, electron-donating groups (EDGs) containing aldehydes were found to be more favorable to the optimized reaction conditions compared to electron-withdrawing groups (EWGs) containing aldehydes. The synthetic utility was also demonstrated by performing a gram-scale synthesis of <strong>3a</strong> by the reaction of <strong>1a</strong> with <strong>2a</strong> under our optimized reaction conditions, which furnished <strong>3a</strong> in 65% isolated yield (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>).</p>
<p class="otherpara">Sequentially, a diverse variety of substituted 2<span class="italic">H</span>-indazoles <strong>1b–m</strong> were reacted with substituted benzaldehyde <strong>2a–b</strong> under the optimized reaction conditions, which furnished the 3-benzyolated-2<span class="italic">H</span>-indazoles <strong>4a–l</strong> in 54–80% yield (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>). 2<span class="italic">H</span>-Indazoles with EDGs, <span class="italic">i.e.</span>, <strong>1b</strong> (R<small><sub>1</sub></small> = –OCH<small><sub>2</sub></small>O–), <strong>1d</strong> (R<small><sub>1</sub></small> = –OCH<small><sub>3</sub></small>), <strong>1e</strong> (R<small><sub>1</sub></small> = CH<small><sub>3</sub></small>) and <strong>1g</strong> (R<small><sub>1</sub></small> = –OCH<small><sub>2</sub></small>O–), were reacted with <strong>2a</strong> under the optimized reaction conditions, which furnished <strong>4a</strong>, <strong>4c</strong>, <strong>4d</strong> and <strong>4f</strong> in 55%, 65%, 68% and 58% moderate yields, respectively. However, 2<span class="italic">H</span>-indazoles with a halo group (R<small><sub>1</sub></small> = F, Cl) <strong>1c</strong> and <strong>1f</strong>, when subjected to CDC reaction with <strong>2a</strong> under the optimized reaction conditions afforded <strong>4b</strong> and <strong>4e</strong> in 71% and 78% yields, respectively. 2<span class="italic">H</span>-Indazoles <strong>1g–i</strong> (R<small><sub>2</sub></small> = <span class="italic">p</span>-OCH<small><sub>3</sub></small>, CH<small><sub>3</sub></small>, Cl) and <strong>1m</strong> (R<small><sub>2</sub></small> = H) on coupling with benzaldehyde <strong>2a</strong> and <strong>2b</strong> afforded C-3 benzoylated product <strong>4f–h</strong> in 58–85% yields and <strong>4l</strong> in 80% yield, respectively. Similarly, heteroaryl 2<span class="italic">H</span>-indazoles <strong>1j–l</strong> were reacted with 4-methylbenzaldehyde <strong>2a</strong>, which furnished 3-benzyolated-(heteroaryl)-2<span class="italic">H</span>-indazoles <strong>4i–k</strong> in 72%, 71% and 82% yields, respectively. The substrates, 2-cyclohexyl-2<span class="italic">H</span>-indazole <strong>1n</strong> and 1<span class="italic">H</span>-indazole <strong>1o</strong> were found to be unreactive under the optimized reaction conditions. This clearly illustrates that the 2-aryl substitution in 2<span class="italic">H</span>-indazole plays a dynamic role in stabilizing the intermediate for the coupling of aldehydes. This transition-metal-free, regioselective, direct C-3 benzoylation of 2-aryl-2<span class="italic">H</span>-indazoles <span class="italic">via</span> a C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–H/C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–H cross-dehydrogenative coupling also works effectively with several substituted benzyl alcohols <strong>5a–e</strong> and styrenes <strong>6a–e</strong> on reaction with <strong>1a</strong>, which furnished C-3-benzoylated-2-aryl-2<span class="italic">H</span>-indazole products <strong>3a–c</strong> and <strong>3e–f</strong> in good yields (<a title="Select to navigate to scheme" href="#imgsch4">Schemes 4</a> and <a title="Select to navigate to scheme" href="#imgsch5">5</a>).</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch3"><a href="/image/article/2021/RA/d1ra02225c/d1ra02225c-s3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1ra02225c-s3.tif" src="/image/article/2021/RA/d1ra02225c/d1ra02225c-s3.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 3 </b> <span id="sch3"><span class="graphic_title">Substrate scope: reaction of different substituted 2<span class="italic">H</span>-indazoles <strong>1b–m</strong> with benzaldehyde <strong>2a–b</strong> for the synthesis of <strong>4a–l</strong><small><sup>a,b</sup></small>. <small><sup>a</sup></small>Reaction conditions: substituted 2<span class="italic">H</span>-indazoles <strong>1b–m</strong> (0.5 mmol), substituted aldehydes <strong>2a–b</strong> (1.0 mmol), oxidant (1.25 mmol), PhCl, N<small><sub>2</sub></small> atm, 110 °C, 24 h. <small><sup>b</sup></small>Isolated yield.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch4"><a href="/image/article/2021/RA/d1ra02225c/d1ra02225c-s4_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1ra02225c-s4.tif" src="/image/article/2021/RA/d1ra02225c/d1ra02225c-s4.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 4 </b> <span id="sch4"><span class="graphic_title">Reaction of oxidative coupling of different substituted benzyl alcohol <strong>5a–e</strong> with 2<span class="italic">H</span>-indazole <strong>1a</strong><small><sup>a,b</sup></small>. <small><sup>a</sup></small>Reaction conditions: 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (0.5 mmol), substituted benzyl alcohols <strong>5a–e</strong> (1.0 mmol), TBPB (1.25 mmol), PhCl, N<small><sub>2</sub></small> atm, 110 °C, 24 h. <small><sup>b</sup></small>Isolated yield.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch5"><a href="/image/article/2021/RA/d1ra02225c/d1ra02225c-s5_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1ra02225c-s5.tif" src="/image/article/2021/RA/d1ra02225c/d1ra02225c-s5.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 5 </b> <span id="sch5"><span class="graphic_title">Benzoylation reaction of different substituted styrenes <strong>6a–e</strong> with 2<span class="italic">H</span>-indazole <strong>1a</strong><small><sup>a,b</sup></small>. <small><sup>a</sup></small>Reaction conditions: 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (0.5 mmol), substituted styrenes <strong>6a–e</strong> (1.0 mmol), TBPB (1.25 mmol), PhCl, N<small><sub>2</sub></small> atm, 110 °C, 24 h. <small><sup>b</sup></small>Isolated yield.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">In order to understand the mechanism of this unique protocol, control experiments were conducted [<a title="Select to navigate to scheme" href="#imgsch6">Scheme 6</a>, <a title="Select to navigate to scheme" href="#imgsch6">eqn (i)–(iv)</a>]. It has already been exemplified in the literature that <span class="italic">tert</span>-butyl peroxybenzoate (TBPB) acts as a radical initiator.<a title="Select to navigate to references" href="#cit11"><sup><span class="sup_ref">11</span></sup></a> Keeping all the reaction conditions the same, <strong>1a</strong> was reacted with <strong>2a</strong> under the optimized reaction conditions in the presence of TEMPO (1 equiv.), which furnished <strong>3a</strong> in 51% yield [<a title="Select to navigate to scheme" href="#imgsch6">Scheme 6</a>, <a title="Select to navigate to scheme" href="#imgsch6">eqn (i)</a>]. However, <strong>3a</strong> was not formed and the reaction was completely aborted when TEMPO (2.5 equiv.) was added under the standard reaction conditions. We were successful in isolating the TEMPO-trapped acyl adduct <strong>7</strong> in 71% yield [<a title="Select to navigate to scheme" href="#imgsch6">Scheme 6</a>, <a title="Select to navigate to scheme" href="#imgsch6">eqn (ii)</a>]. The isolation of adduct <strong>7</strong> confirmed that the synthetic pathway towards the regioselective synthesis of 3-(acyl/benzoyl)-2-aryl-2<span class="italic">H</span>-indazoles proceed <span class="italic">via</span> the free-radical pathway. This underlines the importance of the oxidant in this free-radical-catalyzed reaction. In order to interpret the reactivity order among EDGs and EWGs while keeping all the reaction conditions the same, a competitive experiment was executed in which substrate <strong>1a</strong> was reacted with an equimolar amount of <strong>2c</strong> and <strong>2e</strong>, which afforded the C-3 benzoylated products <strong>3c</strong> and <strong>3e</strong> in 56% and 30% yields, respectively [<a title="Select to navigate to scheme" href="#imgsch6">Scheme 6</a>, <a title="Select to navigate to scheme" href="#imgsch6">eqn (iii)</a>]. Therefore, it has been concluded that <strong>2c</strong> with an EDG showed higher reactivity than <strong>2e</strong> with an EWG. Another competitive experiment was carried out to analyse the reactivity order of this CDC reaction between aliphatic and aromatic aldehydes. Thus, substrate <strong>1a</strong> was reacted with an equimolar amount of <strong>2a</strong> and <strong>2j</strong> under optimized reaction conditions, which furnished 3-(4-methylbenzyolated)-2-aryl-2<span class="italic">H</span>-indazole <strong>3a</strong> and 3-(acetyl)-2-aryl-2<span class="italic">H</span>-indazole <strong>3j</strong> in 55% and 29% yields, respectively [<a title="Select to navigate to scheme" href="#imgsch6">Scheme 6</a>, <a title="Select to navigate to scheme" href="#imgsch6">eqn (iv)</a>]. This reaction demonstrated that the aromatic aldehydes were found to be more reactive than aliphatic aldehydes.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch6"><a href="/image/article/2021/RA/d1ra02225c/d1ra02225c-s6_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1ra02225c-s6.tif" src="/image/article/2021/RA/d1ra02225c/d1ra02225c-s6.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 6 </b> <span id="sch6"><span class="graphic_title">Control experiments.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">A plausible free-radical mechanism for this regioselective benzoylation method has been depicted in <a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a>. Initially, thermal cleavage of TBPB generates a <small><sup><span class="italic">t</span></sup></small>BuO free-radical and a carboxyl (PhCOO) free-radical. Then, the <small><sup><span class="italic">t</span></sup></small>BuO free-radical through hydrogen radical abstraction (HRA) from 4-methylbenzaldehyde <strong>2a</strong> generates a benzoyl (acyl) free-radical <strong>8</strong> [note: the radical species <strong>8</strong> was trapped with TEMPO to give adduct <strong>7</strong>]. The free-radical <strong>8</strong> can also be derived from benzyl alcohol <strong>5a</strong> as well as styrene <strong>6a</strong>.<a title="Select to navigate to reference" href="#cit10a"><sup><span class="sup_ref">10a,b</span></sup></a> This benzoyl free-radical species <strong>8</strong> was regioselectively added to the C-3 position of <strong>1a</strong>. Subsequently, the carboxyl free-radical abstracted the hydrogen radical from the intermediate radical species <strong>9</strong> to afford the desired product <strong>3a</strong>.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig2"><a href="/image/article/2021/RA/d1ra02225c/d1ra02225c-f2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1ra02225c-f2.tif" src="/image/article/2021/RA/d1ra02225c/d1ra02225c-f2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 2 </b> <span id="fig2"><span class="graphic_title">Plausible mechanism.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">To illustrate the synthetic application of the developed CDC methodology, using our optimized reaction conditions, we synthesized the indazole-based anti-inflammatory agent <strong>11</strong> (<a title="Select to navigate to scheme" href="#imgsch7">Scheme 7</a>). The substrate <strong>1p</strong> on reaction with <span class="italic">m</span>-acetoxybenzaldehyde <strong>2r</strong> under the optimized reaction conditions furnished <strong>10</strong>, which on deacetylation furnished anti-inflammatory agent <strong>11</strong> in 51% yield. It has been noted that compound <strong>11</strong> was earlier synthesized in 7 steps;<a title="Select to navigate to references" href="#cit12"><sup><span class="sup_ref">12</span></sup></a> in contrast, we were successful in synthesizing <strong>11</strong> in 51% in two steps. Progressively, the (2-bromophenyl)(2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)methanone <strong>12</strong> was synthesized by the reaction of <strong>1a</strong> with <span class="italic">o</span>-bromobenzaldehyde using our optimized reaction conditions which on further subjection to Pd-catalyzed biaryl coupling leads to the formation of a novel class of heterocycles, <span class="italic">i.e.</span>, 3-methoxy-9<span class="italic">H</span>-dibenzo[4,5:6,7]azepino[1,2-<span class="italic">b</span>]indazol-9-one <strong>13</strong> in 75% yield, which can be utilized for medicinal chemistry applications.<a title="Select to navigate to references" href="#cit13"><sup><span class="sup_ref">13</span></sup></a> In addition, the synthesized benzoylated product <strong>3a</strong> on subjection to NaBH<small><sub>4</sub></small> reduction in methanol furnished the reduced hydroxylated product, <span class="italic">i.e.</span>, (2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)(<span class="italic">p</span>-tolyl)methanol <strong>14</strong>, in 90% yield, which can be utilized further for derivatization/functionalization and other organic transformations.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch7"><a href="/image/article/2021/RA/d1ra02225c/d1ra02225c-s7_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1ra02225c-s7.tif" src="/image/article/2021/RA/d1ra02225c/d1ra02225c-s7.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 7 </b> <span id="sch7"><span class="graphic_title">Practical synthetic applications.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>

<h2 id="sect1039"><span class="a_heading">Conclusions</span></h2>
<span>In summary, we have developed an efficient, cost-effective, transition-metal-free, regioselective, TBPB-promoted, oxidative C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–H/C<small><sub>(sp<small><sup>2</sup></small>)</sub></small>–H cross-dehydrogenative coupling protocol for the direct C-3 acylation/benzoylation of 2-substituted-2<span class="italic">H</span>-indazoles <strong>3a–q</strong>/<strong>4a–l</strong> <span class="italic">via</span> the reaction of various 2-substituted-2<span class="italic">H</span>-indazoles <strong>1a–m</strong> with different substituted aldehydes <strong>2a–q</strong>/benzyl alcohols <strong>5a–e</strong>/styrenes <strong>6a–e</strong> in up to 87% yields. The operationally simple, oxidant-promoted protocol exhibits a variety of functional group tolerances and wide substrate compatibilities. The reaction involves a free-radical mechanism and proceeds <span class="italic">via</span> the addition of an <span class="italic">in situ</span> generated acyl radical (from aldehydes/benzyl alcohols/styrenes) on 2<span class="italic">H</span>-indazoles. The gram-scale synthesis, and facile synthesis of anti-inflammatory agent <strong>11</strong>, 3-methoxy-9<span class="italic">H</span>-dibenzo[4,5:6,7]azepino[1,2-<span class="italic">b</span>]indazol-9-one <strong>13</strong> and hydroxylated product <strong>14</strong> further highlights the versatile nature of the developed methodology. We believe that our acylation/benzoylation regioselective CDC protocol will accomplish several kinds of utilization in constructing a ubiquitous class of bioactive azaheterocycles.</span>

<h2 id="sect1063"><span class="a_heading">Experimental</span></h2>
<h3 id="sect1065"><span class="b_heading">General</span></h3>
<span>Oven-dried laboratory glassware was used for carrying out all the synthetic procedures. Melting points were taken in open capillaries on Sisco melting point apparatus and are presented uncorrected. <small><sup>1</sup></small>H NMR and <small><sup>13</sup></small>C NMR spectra were recorded on a JEOL ECS-400 spectrometer (2-channel console with a flexible broadband RF performance), which was operating at 400 MHz for <small><sup>1</sup></small>H and 100 MHz for <small><sup>13</sup></small>C NMR and utilized CDCl<small><sub>3</sub></small> and DMSO-d6 as solvents for sample preparation. Tetramethylsilane (<span class="italic">δ</span> 0.00 ppm) and CDCl<small><sub>3</sub></small> both served as internal standards in <small><sup>1</sup></small>H NMR (<span class="italic">δ</span> 7.246 ppm) and <small><sup>13</sup></small>C (<span class="italic">δ</span> 77.0 ppm) NMR. Patterns of chemical shifts are reported in parts per million. Peak splitting patterns are described as singlet (s), broad singlet (brs), doublet (d), double doublet (dd), triplet (t), and multiplet (m). Coupling constants (<span class="italic">J</span>) are reported in Hertz (Hz). High-Resolution Electron Impact Mass Spectra (HR-EIMS) were obtained on Xevo G2-S Q-Tof (Waters, USA) compatible with ACQUITY UPLC® and nano ACQUITY UPLC® systems. Column chromatography was performed over normal (particle size: 60–120 mesh, 100–200 mesh) and flash (particle size: 230–400 mesh) silica gel, which was procured from Qualigens™ (India), Rankem (India), and Spectrochem (India). TLC plates coated with silica gel (Kiesel 60-F<small><sub>254</sub></small>, Merck (India)) were used for monitoring the progress of the reactions. The visualizing agents used for TLC was UV light. A BUCHI Rotavapor R-210 was used for all drying and concentration procedures. All the analytical grade supplied solvents such as MeOH, EtOH were used without further purification. All the AR grade chemicals and reagents obtained from Sigma Aldrich (USA), Merck (India), TCI (India) and/or Spectrochem (India) <span class="italic">etc.</span> were used without further purification.</span>

<h3 id="sect1082"><span class="b_heading">Synthesis of starting material 2<span class="italic">H</span>-indazoles <strong>1a–o</strong> (<a title="Select to navigate to scheme" href="#imgsch8">Scheme 8</a>)<a title="Select to navigate to references" href="#cit14"><sup><span class="sup_ref">14</span></sup></a></span></h3>
<span>A solution of 2-bromobenzaldehyde or substituted-2-bromobenzaldehyde (1.5 mmol) and aromatic/hetero-aromatic/aliphatic/cyclic amine (2.4 mmol) in methanol (20 mL) was refluxed for 6–7 h at 80 °C. After the completion of the reaction, the solvent was evaporated under reduced pressure to get the corresponding imine product, which was further used in the next step without prior purification.</span>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch8"><a href="/image/article/2021/RA/d1ra02225c/d1ra02225c-s8_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1ra02225c-s8.tif" src="/image/article/2021/RA/d1ra02225c/d1ra02225c-s8.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 8 </b> <span id="sch8"><span class="graphic_title">General procedure for the synthesis of 2<span class="italic">H</span>-indazole <strong>1a–o</strong>.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">The imine product was dissolved in anhydrous DMSO (10.0 mL) and CuI (38 mg, 0.20 mmol), NaN<small><sub>3</sub></small> (261 mg, 4.0 mmol) and TMEDA (22 mg, 0.20 mmol) were added. The reaction mixture was heated at 120 °C for 12 h. After cooling the reaction mixture, it was poured into chloroform (70.0 mL) and sequentially washed with water (3 × 30 mL) and brine (3 × 30 mL), then dried over anhyd. Na<small><sub>2</sub></small>SO<small><sub>4</sub></small>. Then, after evaporation of the solvent under reduced pressure, the crude product was further purified by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 99<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1 to 90<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>10) to produce the corresponding 2<span class="italic">H</span>-indazole <strong>1a–m</strong>.</p>

<h3 id="sect1099"><span class="b_heading">Synthetic procedure for the C-3 benzoylation of 2<span class="italic">H</span>-indazoles <strong>3a–q</strong>/<strong>4a–l</strong> (<a title="Select to navigate to scheme" href="#imgsch2">Schemes 2</a> and <a title="Select to navigate to scheme" href="#imgsch3">3</a>)</span></h3>
<span>For the C-3 benzoylation of 2<span class="italic">H</span>-indazoles <strong>3a–q</strong>/<strong>4a–l</strong>, a mixture of 2<span class="italic">H</span>-indazole <strong>1a–m</strong> (0.5 mmol), aromatic/hetero-aromatic/aliphatic aldehydes <strong>2a–q</strong> (1 mmol) and TBPB (1.25 mmol) dissolved in PhCl were taken in a sealed reaction tube under nitrogen atmosphere. Then the reaction mixture was stirred at 110 °C for 24 h. After completion of the reaction, the reaction mixture was cooled and the work-up was done with a saturated solution of NaHCO<small><sub>3</sub></small> (10 mL) and ethyl acetate (3 × 20 mL). The combined organic layers were dried over anhydrous Na<small><sub>2</sub></small>SO<small><sub>4</sub></small>, filtered, and concentrated under reduced pressure to get the crude residue which was further purified through column chromatography on silica gel (100–200 mesh) using hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>ethyl acetate (95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>5 ratio) as an eluent to afford the corresponding desired product.</span>

<h3 id="sect1116"><span class="b_heading">General procedure for the gram-scale synthesis of compound <strong>3a</strong></span></h3>
<span>A mixture of 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (1.0 g, 4.46 mmol), 4-methyl benzaldehyde <strong>2a</strong> (1.05 mL, 8.92 mmol) and TBPB (2.12 mL, 11.15 mmol) was taken in a 50 mL round-bottom flask under nitrogen atmosphere. Then, the reaction mixture was stirred at 110 °C for 24 h. After completion of the reaction, the reaction mixture was cooled and the work-up was done with a saturated solution of NaHCO<small><sub>3</sub></small> (10 mL) and ethyl acetate (3 × 20 mL). The combined organic layers were dried over anhydrous Na<small><sub>2</sub></small>SO<small><sub>4</sub></small>, filtered, and concentrated under reduced pressure to get the crude residue which was further purified through column chromatography on silica gel (100–200 mesh) using hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>ethyl acetate (95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>5 ratio) as an eluent to afford compound <strong>3a</strong> as a yellow solid in 65% yield (0.97 g).</span>

<h3 id="sect1127"><span class="b_heading">Characterization of C-3 acylated/benzoylated 2<span class="italic">H</span>-indazoles</span></h3>
<div><span id="sect1130"/><span class="c_heading_indent">2-(4-Methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)(<span class="italic">p</span>-tolyl)methanone (<strong>3a</strong>). </span><span>Product <strong>3a</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and 4-methyl benzaldehyde <strong>2a</strong> (118 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 82% yield (140 mg, 0.40 mmol); mp: 153–155 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.48; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-d) <span class="italic">δ</span> 7.86 (d, <span class="italic">J</span> = 8.4 Hz, 1H), 7.79 (d, <span class="italic">J</span> = 8.0 Hz, 2H), 7.49–7.44 (m, 2H), 7.38–7.33 (m, 2H), 7.27 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 7.17–7.13 (m, 1H), 6.93 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 3.82 (s, 3H), 2.44 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-d) <span class="italic">δ</span> 185.87, 159.94, 148.41, 144.80, 135.37, 133.75, 132.41, 130.29, 129.47, 126.89, 126.70, 124.69, 123.86, 120.68, 118.44, 114.33, 55.63, 21.89; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>22</sub></small>H<small><sub>18</sub></small>N<small><sub>2</sub></small>O<small><sub>2</sub></small>, 343.1441 [M + H]<small><sup>+</sup></small>; found, 343.1446.</span></div>
<div><span id="sect1158"/><span class="c_heading_indent">(2-(4-Methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)(phenyl)-methanone (<strong>3b</strong>). </span><span>Product <strong>3b</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and benzaldehyde <strong>2b</strong> (102 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 80% yield (131 mg, 0.39 mmol); mp: 93–95 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.45; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.88–7.84 (m, 3H), 7.59 (t, <span class="italic">J</span> = 7.2 Hz, 1H), 7.47–7.43 (m, 4H), 7.38–7.32 (m, 2H), 7.17–7.13 (m, 1H), 6.91 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 3.81 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 186.15, 159.99, 148.46, 137.99, 133.74, 133.63, 132.20, 130.01, 128.73, 126.95, 126.78, 124.95, 124.05, 120.63, 118.51, 114.33, 55.63; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>21</sub></small>H<small><sub>16</sub></small>N<small><sub>2</sub></small>O<small><sub>2</sub></small>, 329.1285 [M + H]<small><sup>+</sup></small>; found, 329.1282.</span></div>
<div><span id="sect1185"/><span class="c_heading_indent">(4-Methoxyphenyl)(2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)methanone (<strong>3c</strong>). </span><span>Product <strong>3c</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and 4-methoxybenzaldehyde <strong>2c</strong> (121 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 86% yield (154 mg, 0.43 mmol); mp: 123–125 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.38; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.89–7.83 (m, 3H), 7.47–7.44 (m, 2H), 7.39–7.33 (m, 2H), 7.16–7.12 (m, 1H), 6.94–6.91 (m, 4H), 3.87 (s, 3H), 3.81 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 184.89, 164.25, 159.91, 148.39, 133.73, 132.63, 132.51, 130.67, 126.90, 126.63, 124.56, 123.71, 120.65, 118.40, 114.35, 114.07, 55.70, 55.64; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>22</sub></small>H<small><sub>18</sub></small>N<small><sub>2</sub></small>O<small><sub>3</sub></small>, 359.1390 [M + H]<small><sup>+</sup></small>; found, 359.1392.</span></div>
<div><span id="sect1210"/><span class="c_heading_indent">(2,5-Dimethoxyphenyl)(2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)methanone (<strong>3d</strong>). </span><span>Product <strong>3d</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and 2,5-dimethoxybenzaldehyde <strong>2d</strong> (166 mg, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a brown oil in 78% yield (152 mg, 0.39 mmol); <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.30; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.84 (d, <span class="italic">J</span> = 8.8 Hz, 1H), 7.44 (d, <span class="italic">J</span> = 9.2 Hz, 2H), 7.35–7.33 (m, 2H), 7.17–7.14 (m, 1H), 7.04 (d, <span class="italic">J</span> = 3.2 Hz, 1H), 6.99–6.96 (m, 1H), 6.88 (d, <span class="italic">J</span> = 9.2 Hz, 2H), 6.74 (d, <span class="italic">J</span> = 9.2 Hz, 1H), 3.80 (s, 3H), 3.76 (s, 3H), 3.48 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 184.23, 159.38, 153.19, 151.66, 147.87, 133.21, 133.15, 128.89, 126.53, 126.34, 124.61, 123.37, 120.08, 118.91, 117.86, 113.95, 113.37, 112.36, 55.70, 55.49, 55.13. HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>23</sub></small>H<small><sub>20</sub></small>N<small><sub>2</sub></small>O<small><sub>4</sub></small>, 389.1496 [M + H]<small><sup>+</sup></small>; found, 389.1498.</span></div>
<div><span id="sect1240"/><span class="c_heading_indent">(4-Fluorophenyl)(2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)methanone (<strong>3e</strong>). </span><span>Product <strong>3e</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and 4-flurobenzaldehyde <strong>2e</strong> (106 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 83% yield (143 mg, 0.41 mmol); mp: 135–137 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.42; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.92–7.87 (m, 3H), 7.46–7.44 (m, 2H), 7.40–7.36 (m, 2H), 7.22–7.18 (m, 1H), 7.14 (t, <span class="italic">J</span> = 8.8 Hz, 2H), 6.94 (d, <span class="italic">J</span> = 9.2 Hz, 2H), 3.83 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 184.52, 165.94 (<span class="italic">J</span><small><sub>C-F</sub></small> = 254.7 Hz), 159.96, 148.37, 134.18 (<span class="italic">J</span><small><sub>C-F</sub></small> = 2.9 Hz), 133.52, 132.60 (<span class="italic">J</span><small><sub>C-F</sub></small> = 9.4 Hz), 131.81, 126.95, 126.65, 125.03, 123.90, 120.30, 118.52, 115.91 (<span class="italic">J</span><small><sub>C-F</sub></small> = 22.0 Hz), 114.28, 55.57; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>21</sub></small>H<small><sub>15</sub></small>FN<small><sub>2</sub></small>O<small><sub>2</sub></small>, 347.1191 [M + H]<small><sup>+</sup></small>; found, 347.1194.</span></div>
<div><span id="sect1275"/><span class="c_heading_indent">(4-Chlorophenyl)(2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)methanone (<strong>3f</strong>). </span><span>Product <strong>3f</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and 4-chlorobenzaldehyde <strong>2f</strong> (141 mg, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 81% yield (147 mg, 0.41 mmol); mp: 142–144 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.45; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.86 (d, <span class="italic">J</span> = 8.8 Hz, 1H), 7.78 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 7.44–7.40 (m, 4H), 7.37–7.33 (m, 2H), 7.19–7.16 (m, 1H), 6.91 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 3.81 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 184.77, 160.07, 148.45, 140.09, 136.28, 133.57, 131.75, 131.36, 129.09, 127.05, 126.76, 125.23, 124.01, 120.38, 118.63, 114.37, 55.65; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>21</sub></small>H<small><sub>15</sub></small>ClN<small><sub>2</sub></small>O<small><sub>2</sub></small>, 363.0895 [M + H]<small><sup>+</sup></small>; found, 363.0897.</span></div>
<div><span id="sect1303"/><span class="c_heading_indent">(4-Bromophenyl)(2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)methanone (<strong>3g</strong>). </span><span>Product <strong>3g</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and 4-bromobenzaldehyde <strong>2g</strong> (165 mg, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 84% yield (170 mg, 0.42 mmol); mp: 141–143 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.48; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.89–7.87 (m, 1H), 7.73 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 7.61 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 7.44 (d, <span class="italic">J</span> = 9.2 Hz, 2H), 7.45–7.35 (m, 2H), 7.22–7.18 (m, 1H), 6.94 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 3.84 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 184.93, 160.08, 148.46, 136.71, 133.56, 132.07, 131.70, 131.43, 128.83, 127.05, 126.76, 125.26, 124.00, 120.38, 118.64, 114.38, 55.66; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>21</sub></small>H<small><sub>15</sub></small>BrN<small><sub>2</sub></small>O<small><sub>2</sub></small>, 407.0390 [M + H]<small><sup>+</sup></small>; found, 407.0392.</span></div>
<div><span id="sect1332"/><span class="c_heading_indent">(3-Chlorophenyl)(2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)methanone (<strong>3h</strong>). </span><span>Product <strong>3h</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and 3-chlorobenzaldehyde <strong>2h</strong> (141 mg, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 67% yield (122 mg, 0.34 mmol); mp: 155–157 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.44; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.88 (d, <span class="italic">J</span> = 8.8 Hz, 1H), 7.78 (s, 1H), 7.69 (d, <span class="italic">J</span> = 7.6 Hz, 1H), 7.54 (d, <span class="italic">J</span> = 8.0 Hz, 1H), 7.43–7.37 (m, 5H), 7.23–7.19 (m, 1H), 6.92 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 3.81 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 184.63, 160.07, 148.51, 139.52, 134.98, 133.57, 133.37, 131.66, 130.01, 129.76, 128.03, 127.11, 126.81, 125.45, 124.20, 120.37, 118.66, 114.37, 55.66; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>21</sub></small>H<small><sub>15</sub></small>ClN<small><sub>2</sub></small>O<small><sub>2</sub></small>, 363.0895 [M + H]<small><sup>+</sup></small>; found, 363.0892.</span></div>
<div><span id="sect1361"/><span class="c_heading_indent">(2-Chlorophenyl)(2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)methanone (<strong>3i</strong>). </span><span>Product <strong>3i</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.4459 mmol) and 2-chlorobenzaldehyde <strong>2i</strong> (141 mg, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 58% yield (105 mg, 0.29 mmol); mp: 90–92 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.44; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.8–7.78 (m, 1H), 7.39 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 7.36–7.24 (m, 5H), 7.14–7.09 (m, 1H), 7.06–7.04 (m, 1H), 6.84 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 3.75 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 183.82, 160.11, 148.53, 138.80, 133.59, 132.21, 132.16, 131.94, 130.37, 129.90, 127.20, 127.09, 126.08, 124.52, 120.20, 118.77, 114.09, 55.68; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>21</sub></small>H<small><sub>15</sub></small>ClN<small><sub>2</sub></small>O<small><sub>2</sub></small>, 363.0895 [M + H]<small><sup>+</sup></small>; found, 363.0898.</span></div>
<div><span id="sect1388"/><span class="c_heading_indent">1-(2-(4-Methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)ethan-1-one (<strong>3j</strong>). </span><span>Product <strong>3j</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and acetaldehyde <strong>2j</strong> (57 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow oil in 68% yield (90 mg, 0.34 mmol); <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.36; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.70–7.68 (m, 1H), 7.60 (d, <span class="italic">J</span> = 8.4 Hz, 1H), 7.45 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 7.32–7.28 (m, 1H), 7.06–7.00 (m, 3H), 3.87 (s, 3H), 2.60 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 188.07, 159.75, 148.49, 133.02, 132.07, 127.53, 127.06, 126.70, 120.86, 120.02, 117.52, 114.37, 55.69, 11.12; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>16</sub></small>H<small><sub>14</sub></small>N<small><sub>2</sub></small>O<small><sub>2</sub></small>, 267.1128 [M + H]<small><sup>+</sup></small>; found, 267.1131.</span></div>
<div><span id="sect1415"/><span class="c_heading_indent">1-(2-(4-Methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)propan-1-one (<strong>3k</strong>). </span><span>Product <strong>3k</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and propionaldehyde <strong>2k</strong> (73 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow oil in 61% yield (86 mg, 0.31 mmol); <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.31; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.86–7.59 (m, 2H), 7.47–7.40 (m, 2H), 7.31–7.28 (m, 1H), 7.07–7.00 (m, 3H), 3.87 (s, 3H), 3.02 (q, <span class="italic">J</span> = 7.6 Hz, 1H), 2.60 (s, 1H), 1.27–1.23 (m, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 188.08, 159.92, 159.76, 148.55, 138.10, 133.09, 127.36, 127.06, 126.59, 120.86, 120.84, 120.15, 117.61, 114.36, 55.68, 18.91, 14.15; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>17</sub></small>H<small><sub>16</sub></small>N<small><sub>2</sub></small>O<small><sub>2</sub></small>, 281.1285 [M + H]<small><sup>+</sup></small>; found, 281.1287.</span></div>
<div><span id="sect1441"/><span class="c_heading_indent">1-(2-(4-Methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)butan-1-one (<strong>3l</strong>). </span><span>Product <strong>3l</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and butyraldehyde <strong>2l</strong> (90 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow oil in 60% yield (88 mg, 0.30 mmol); <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.32; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.70–7.64 (m, 2H), 7.45–7.40 (m, 2H), 7.31–7.27 (m, 1H), 7.06–7.00 (m, 3H), 3.87 (s, 3H), 2.96 (t, <span class="italic">J</span> = 7.6 Hz, 2H), 1.66 (q, <span class="italic">J</span> = 7.6 Hz, 2H), 0.88 (t, <span class="italic">J</span> = 7.2 Hz, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 159.89, 148.49, 136.89, 133.16, 127.49, 127.06, 126.56, 120.84, 120.29, 117.58, 114.37, 114.32, 55.68, 27.36, 22.87, 14.08; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>17</sub></small>H<small><sub>18</sub></small>N<small><sub>2</sub></small>O, 267.1492 [M + H]<small><sup>+</sup></small>; found, 267.1495.</span></div>
<div><span id="sect1468"/><span class="c_heading_indent">1-(2-(4-Methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)-2-methylpropan-1-one (<strong>3m</strong>). </span><span>Product <strong>3m</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and isobutyraldehyde <strong>2m</strong> (91 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 71% yield (104 mg, 0.35 mmol); mp: 98–100 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.34; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.81 (dd, <span class="italic">J</span> = 8.4 Hz, 0.8 Hz, 1H), 7.69 (d, <span class="italic">J</span> = 8.8 Hz, 1H), 7.39–7.37 (m, 2H), 7.30–7.26 (m, 1H), 7.03–7.00 (m, 3H), 3.87 (s, 3H), 3.36–3.29 (m, 1H), 1.46 (d, <span class="italic">J</span> = 7.2 Hz, 6H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 160.01, 148.77, 142.10, 133.18, 127.70, 126.28, 120.97, 120.56, 119.06, 117.86, 114.29, 55.69, 27.20, 22.51; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>17</sub></small>H<small><sub>18</sub></small>N<small><sub>2</sub></small>O, 267.1492 [M + H]<small><sup>+</sup></small>; found, 267.1498.</span></div>
<div><span id="sect1495"/><span class="c_heading_indent">(2-(4-Methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)(1<span class="italic">H</span>-pyrrol-2-yl)methanone (<strong>3n</strong>). </span><span>Product <strong>3n</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and 1<span class="italic">H</span>-pyrrole-2-carbaldehyde <strong>2n</strong> (95 mg, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a brown solid in 58% yield (92 mg, 0.29 mmol); mp: 134–136 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.29; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 10.35 (b, 1H), 7.84 (d, <span class="italic">J</span> = 8.8 Hz, 1H), 7.74 (dd, <span class="italic">J</span> = 8.4 Hz, 0.8 Hz, 1H), 7.51–7.49 (m, 2H), 7.38–7.34 (m, 1H), 7.21–7.17 (m, 1H), 7.03 (s, 1H), 6.96–6.94 (m, 3H), 6.33–6.31 (m, 1H), 3.83 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 174.34, 159.87, 148.50, 133.85, 132.45, 132.25, 127.24, 126.95, 126.66, 124.31, 123.14, 121.36, 120.80, 118.21, 114.29, 111.60, 55.65; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>19</sub></small>H<small><sub>15</sub></small>N<small><sub>3</sub></small>O<small><sub>2</sub></small>, 318.1237 [M + H]<small><sup>+</sup></small>; found, 318.1233.</span></div>
<div><span id="sect1524"/><span class="c_heading_indent">Furan-2-yl(2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)methanone (<strong>3o</strong>). </span><span>Product <strong>3o</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and furan-2-aldehyde <strong>2o</strong> (83 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a brown solid in 57% yield (91 mg, 0.28 mmol); mp: 70–72 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.29; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.85 (d, <span class="italic">J</span> = 9.6 Hz, 1H), 7.68 (d, <span class="italic">J</span> = 8.4 Hz, 1H), 7.60 (b, 1H), 7.46 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 7.40–7.36 (m, 1H), 7.24–7.20 (m, 2H), 6.93 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 6.56–6.54 (m, 1H), 3.81 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 178.93, 172.80, 159.93, 152.39, 148.49, 147.78, 133.70, 127.06, 126.55, 124.94, 123.70, 121.20, 120.42, 118.45, 114.35, 112.79, 55.64; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>19</sub></small>H<small><sub>14</sub></small>N<small><sub>2</sub></small>O<small><sub>3</sub></small>, 319.1077 [M + H]<small><sup>+</sup></small>; found, 319.1073.</span></div>
<div><span id="sect1553"/><span class="c_heading_indent">(2-(4-Methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)(5-methylfuran-2-yl)methanone (<strong>3p</strong>). </span><span>Product <strong>3p</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and 5-methylfuran-2-carboxaldehyde <strong>2p</strong> (99 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a brown solid in 61% yield (101 mg, 0.30 mmol); mp: 76–78 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.24; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.83 (d, <span class="italic">J</span> = 9.2 Hz, 1H), 7.72 (d, <span class="italic">J</span> = 8.8 Hz, 1H), 7.48 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 7.39–7.35 (m, 1H), 7.24–7.19 (m, 1H), 7.12 (dd, <span class="italic">J</span> = 3.6, 0.7 Hz, 1H), 6.93 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 6.17–6.16 (m, 1H), 3.82 (s, 3H), 2.33 (s, 3H); <small><sup>13</sup></small>C NMR (101 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 172.24, 159.88, 159.60, 151.18, 148.50, 133.84, 131.85, 127.02, 126.44, 124.64, 123.63, 120.52, 118.32, 114.31, 109.71, 55.66, 14.18; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>20</sub></small>H<small><sub>16</sub></small>N<small><sub>2</sub></small>O<small><sub>3</sub></small>, 333.1234 [M + H]<small><sup>+</sup></small>; found, 333.1235.</span></div>
<div><span id="sect1583"/><span class="c_heading_indent">(5-Bromothiophen-2-yl)(2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)methanone (<strong>3q</strong>). </span><span>Product <strong>3q</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch2">Scheme 2</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol) and 5-bromothiophene-2-carboxaldehyde <strong>2q</strong> (119 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 59% yield (122 mg, 0.29 mmol); mp: 70–72 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.34; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.78 (d, <span class="italic">J</span> = 8.8 Hz, 1H), 7.56 (d, <span class="italic">J</span> = 8.8 Hz, 1H), 7.39 (d, <span class="italic">J</span> = 9.2 Hz, 2H), 7.33–7.29 (m, 2H), 7.17–7.13 (m, 1H), 7.02–7.03 (m, 1H), 6.88 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 3.76 (s, 3H); <small><sup>13</sup></small>C NMR (101 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 176.80, 160.09, 148.49, 145.70, 135.74, 133.39, 131.53, 131.17, 127.12, 126.59, 125.03, 124.85, 123.46, 120.22, 118.55, 114.45, 55.67; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>19</sub></small>H<small><sub>13</sub></small>BrN<small><sub>2</sub></small>O<small><sub>2</sub></small>S, 412.9954 [M + H]<small><sup>+</sup></small>; found, 412.9957.</span></div>
<div><span id="sect1612"/><span class="c_heading_indent">(2-Phenyl-2<span class="italic">H</span>-[1,3]dioxolo[4,5-<span class="italic">f</span>]indazol-3-yl)(<span class="italic">p</span>-tolyl)methanone (<strong>4a</strong>). </span><span>Product <strong>4a</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>) using 2-phenyl-2<span class="italic">H</span>-[1,3]dioxolo[4,5-<span class="italic">f</span>]indazole <strong>1b</strong> (119 mg, 0.5 mmol) and 4-methylbenzaldehyde <strong>2b</strong> (118 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow oil in 55% yield (91 mg, 0.26 mmol); <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.40; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.75 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 7.47–7.45 (m, 2H), 7.39–7.35 (m, 4H), 7.23 (s, 1H), 7.08 (s, 1H), 6.58 (s, 1H), 5.98 (s, 2H), 2.41 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 185.80, 149.62, 147.86, 146.11, 144.59, 140.49, 135.13, 132.16, 130.03, 129.39, 129.00, 128.34, 125.08, 120.78, 101.40, 95.69, 94.54, 21.79; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>22</sub></small>H<small><sub>16</sub></small>N<small><sub>2</sub></small>O<small><sub>3</sub></small>, 357.1234 [M + H]<small><sup>+</sup></small>; found, 357.1239.</span></div>
<div><span id="sect1641"/><span class="c_heading_indent">(5-Fluoro-2-phenyl-2<span class="italic">H</span>-indazol-3-yl)(<span class="italic">p</span>-tolyl)methanone (<strong>4b</strong>). </span><span>Product <strong>4b</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>) using 5-fluoro-2-phenyl-2<span class="italic">H</span>-indazole <strong>1c</strong> (106 mg, 0.5 mmol) and 4-methylbenzaldehyde <strong>2b</strong> (118 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as an off-white solid in 71% yield (101 mg, 0.31 mmol); mp: 65–67 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.51; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.88–7.84 (m, 1H), 7.78 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 7.54–7.51 (m, 2H), 7.44–7.42 (m, 3H), 7.28 (d, <span class="italic">J</span> = 7.6 Hz, 2H), 7.18 (td, <span class="italic">J</span> = 9.2, 2.4 Hz, 1H), 6.97–6.94 (m, 1H), 2.45 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 185.31, 160.09 (<span class="italic">J</span><small><sub>C-F</sub></small> = 243.3 Hz), 145.89, 144.94, 140.39, 134.92, 130.05, 129.51, 129.14, 129.02, 125.35, 123.78 (<span class="italic">J</span><small><sub>C-F</sub></small> = 11.9 Hz), 120.77 (<span class="italic">J</span><small><sub>C-F</sub></small> = 9.9 Hz), 118.67 (<span class="italic">J</span><small><sub>C-F</sub></small> = 29.0 Hz), 103.63 (<span class="italic">J</span><small><sub>C-F</sub></small> = 25.5 Hz), 97.22, 21.83.3; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>21</sub></small>H<small><sub>15</sub></small>FN<small><sub>2</sub></small>O, 331.1241 [M + H]<small><sup>+</sup></small>; found, 331.1244.</span></div>
<div><span id="sect1679"/><span class="c_heading_indent">(5-Methoxy-2-phenyl-2<span class="italic">H</span>-indazol-3-yl)(<span class="italic">p</span>-tolyl)methanone (<strong>4c</strong>). </span><span>Product <strong>4c</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>) using 5-methoxy-2-phenyl-2<span class="italic">H</span>-indazole <strong>1d</strong> (112 mg, 0.5 mmol) and 4-methylbenzaldehyde <strong>2b</strong> (118 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a brown solid in 65% yield (111 mg, 0.32 mmol); mp: 140–142 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.48; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.75–7.72 (m, 3H), 7.48–7.46 (m, 2H), 7.36–7.32 (m, 3H), 7.20 (d, <span class="italic">J</span> = 7.2 Hz, 2H), 7.07–7.04 (m, 1H), 6.67 (s, 1H), 3.68 (s, 3H), 2.39 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 185.93, 157.54, 145.56, 144.41, 140.72, 135.32, 131.84, 130.07, 129.29, 129.08, 128.61, 125.39, 125.01, 122.14, 119.92, 97.13, 55.44, 21.84; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>22</sub></small>H<small><sub>18</sub></small>N<small><sub>2</sub></small>O<small><sub>2</sub></small>, 343.1441 [M + H]<small><sup>+</sup></small>; found, 343.1445.</span></div>
<div><span id="sect1706"/><span class="c_heading_indent">(6-Methyl-2-phenyl-2<span class="italic">H</span>-indazol-3-yl)(<span class="italic">p</span>-tolyl)methanone (<strong>4d</strong>). </span><span>Product <strong>4d</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>) using 6-methyl-2-phenyl-2<span class="italic">H</span>-indazole <strong>1e</strong> (104 mg, 0.5 mmol) and 4-methylbenzaldehyde <strong>2b</strong> (118 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 68% yield (111 mg, 0.34 mmol); mp: 102–104 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.44; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.80 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 7.61 (s, 1H), 7.53–7.38 (m, 6H), 7.27–7.25 (m, 2H), 7.00 (d, <span class="italic">J</span> = 8.8 Hz, 1H), 2.47 (s, 3H), 2.44 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 185.70, 149.13, 144.67, 140.56, 136.99, 135.24, 132.28, 130.18, 129.35, 129.04, 128.71, 127.75, 125.43, 122.38, 120.14, 116.69, 22.08, 21.80; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>22</sub></small>H<small><sub>18</sub></small>N<small><sub>2</sub></small>O, 327.1492 [M + H]<small><sup>+</sup></small>; found, 327.1494.</span></div>
<div><span id="sect1733"/><span class="c_heading_indent">(5-Chloro-2-phenyl-2<span class="italic">H</span>-indazol-3-yl)(<span class="italic">p</span>-tolyl)methanone (<strong>4e</strong>). </span><span>Product <strong>4e</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>) using 5-chloro-2-phenyl-2<span class="italic">H</span>-indazole <strong>1f</strong> (114 mg, 0.5 mmol) and 4-methylbenzaldehyde <strong>2b</strong> (118 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 78% yield (134 mg, 0.39 mmol); mp: 158–160 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.50; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.81 (dd, <span class="italic">J</span> = 9.2 Hz, 0.8 Hz, 1H), 7.76 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 7.52–7.50 (m, 2H), 7.42–7.37 (m, 4H), 7.32–7.26 (m, 3H), 2.26 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 185.29, 146.83, 145.14, 140.22, 134.78, 132.19, 130.71, 130.11, 129.55, 129.16, 129.09, 128.54, 125.33, 124.19, 120.00, 119.36, 21.85; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>21</sub></small>H<small><sub>15</sub></small>ClN<small><sub>2</sub></small>O, 347.0946 [M + H]<small><sup>+</sup></small>; found, 347.0947.</span></div>
<div><span id="sect1760"/><span class="c_heading_indent">(2-(4-Methoxyphenyl)-2<span class="italic">H</span>-[1,3]dioxolo[4,5-<span class="italic">f</span>]indazol-3-yl)(<span class="italic">p</span>-tolyl)methanone (<strong>4f</strong>). </span><span>Product <strong>4f</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>) using 2-(4-methoxyphenyl)-2<span class="italic">H</span>-[1,3]dioxolo[4,5-<span class="italic">f</span>]indazole <strong>1g</strong> (134 mg, 0.5 mmol) and 4-methylbenzaldehyde <strong>2b</strong> (118 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow oil in 58% yield (112 mg, 0.29 mmol); <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.40; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.75 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 7.39 (dd, <span class="italic">J</span> = 6.8 Hz, 2.0 Hz, 2H), 7.26 (s, 2H), 7.09 (s, 1H), 6.90 (dd, <span class="italic">J</span> = 6.8 Hz, 2.0 Hz, 2H), 6.56 (s, 1H), 5.99 (s, 2H), 3.81 (s, 3H), 2.44 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 185.62, 159.25, 149.25, 147.49, 145.60, 144.32, 135.00, 133.54, 131.87, 129.82, 129.17, 126.08, 120.30, 113.95, 101.14, 95.52, 94.31, 55.31, 21.58; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>23</sub></small>H<small><sub>18</sub></small>N<small><sub>2</sub></small>O<small><sub>4</sub></small>, 387.1340 [M + H]<small><sup>+</sup></small>; found, 387.1346.</span></div>
<div><span id="sect1791"/><span class="c_heading_indent"><span class="italic">p</span>-Tolyl(2-(<span class="italic">p</span>-tolyl)-2<span class="italic">H</span>-indazol-3-yl)methanone (<strong>4g</strong>). </span><span>Product <strong>4g</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>) using 2-(<span class="italic">p</span>-tolyl)-2<span class="italic">H</span>-indazole <strong>1h</strong> (104 mg, 0.5 mmol) and 4-methylbenzaldehyde <strong>2b</strong> (118 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 79% yield (129 mg, 0.40 mmol); mp: 167–169 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.48; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.87 (dd, <span class="italic">J</span> = 8.4 Hz, 0.8 Hz, 1H), 7.81 (d, <span class="italic">J</span> = 8.0 Hz, 2H), 7.42 (d, <span class="italic">J</span> = 8.0 Hz, 2H), 7.35 (t, <span class="italic">J</span> = 8.4 Hz, 2H), 7.27 (d, <span class="italic">J</span> = 8.0 Hz, 2H), 7.22 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 7.16–7.13 (m, 1H), 2.44 (s, 3H), 2.38 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 185.71, 148.38, 144.72, 138.94, 138.08, 135.22, 132.33, 130.21, 129.67, 129.37, 126.81, 125.17, 124.62, 123.79, 120.59, 118.41, 21.80, 21.19; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>22</sub></small>H<small><sub>18</sub></small>N<small><sub>2</sub></small>O, 327.1492 [M + H]<small><sup>+</sup></small>; found, 327.1495.</span></div>
<div><span id="sect1824"/><span class="c_heading_indent">(2-(4-Chlorophenyl)-2<span class="italic">H</span>-indazol-3-yl)(<span class="italic">p</span>-tolyl)methanone (<strong>4h</strong>). </span><span>Product <strong>4h</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>) using 2-(4-chlorophenyl)-2<span class="italic">H</span>-indazole <strong>1i</strong> (114 mg, 0.5 mmol) and 4-methylbenzaldehyde <strong>2b</strong> (118 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow semi-solid in 85% yield (142 mg, 0.41 mmol); <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.48; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.86 (dd, <span class="italic">J</span> = 8.8 Hz, 0.8 Hz, 1H), 7.81 (d, <span class="italic">J</span> = 8.0 Hz, 2H), 7.52–7.48 (m, 2H), 7.41 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 7.38–7.33 (m, 2H), 7.30 (d, <span class="italic">J</span> = 8.0 Hz, 2H), 7.19–7.15 (m, 1H), 2.46 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 185.59, 148.70, 145.14, 139.10, 135.13, 134.90, 132.54, 130.30, 129.58, 129.35, 127.29, 126.74, 125.12, 123.97, 120.72, 118.55, 21.93; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>21</sub></small>H<small><sub>15</sub></small>ClN<small><sub>2</sub></small>O, 347.0946 [M + H]<small><sup>+</sup></small>; found, 347.0942.</span></div>
<div><span id="sect1853"/><span class="c_heading_indent">(2-(5-Methylpyridin-2-yl)-2<span class="italic">H</span>-indazol-3-yl)(<span class="italic">p</span>-tolyl)methanone (<strong>4i</strong>). </span><span>Product <strong>4i</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>) using 2-(5-methylpyridin-2-yl)-2<span class="italic">H</span>-indazole <strong>1j</strong> (105 mg, 0.5 mmol) and 4-methylbenzaldehyde <strong>2b</strong> (118 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 72% yield (118 mg, 0.36 mmol); mp: 130–132 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.34; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 8.08 (s, 1H), 7.91 (d, <span class="italic">J</span> = 8.0 Hz, 1H), 7.83 (d, <span class="italic">J</span> = 8.8 Hz, 1H), 7.79 (d, <span class="italic">J</span> = 8.0 Hz, 2H), 7.69–7.66 (m, 1H), 7.43 (d, <span class="italic">J</span> = 8.8 Hz, 1H), 7.38–7.34 (m, 1H), 7.24 (d, <span class="italic">J</span> = 7.6 Hz, 2H), 7.15–7.11 (m, 1H), 2.42 (s, 3H), 2.32 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 186.88, 149.95, 148.92, 148.30, 144.37, 139.19, 135.40, 133.35, 132.60, 129.95, 129.39, 127.60, 124.43, 123.49, 120.67, 118.40, 116.99, 21.86, 18.10; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>21</sub></small>H<small><sub>17</sub></small>N<small><sub>3</sub></small>O, 328.1445 [M + H]<small><sup>+</sup></small>; found, 328.1449.</span></div>
<div><span id="sect1883"/><span class="c_heading_indent">(2-(5-Chloropyridin-2-yl)-2<span class="italic">H</span>-indazol-3-yl)(<span class="italic">p</span>-tolyl)methanone (<strong>4j</strong>). </span><span>Product <strong>4j</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>) using 2-(5-chloropyridin-2-yl)-2<span class="italic">H</span>-indazole <strong>1k</strong> (115 mg, 0.5 mmol) and 4-methylbenzaldehyde <strong>2b</strong> (118 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a white solid in 71% yield (124 mg, 0.35 mmol); mp: 104–106 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.38; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 8.18–8.17 (m, 1H), 8.03–8.00 (m, 1H), 7.85–7.75 (m, 4H), 7.42–7.34 (m, 2H), 7.24 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 7.14–7.10 (m, 1H), 2.41 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 186.65, 150.10, 149.12, 146.77, 144.62, 138.41, 135.09, 132.81, 131.34, 129.85, 129.42, 127.98, 124.70, 123.56, 120.59, 118.33, 118.07, 21.80; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>20</sub></small>H<small><sub>14</sub></small>ClN<small><sub>3</sub></small>O, 348.0898 [M + H]<small><sup>+</sup></small>; found, 348.0895.</span></div>
<div><span id="sect1909"/><span class="c_heading_indent">(2-(Pyridin-2-yl)-2<span class="italic">H</span>-indazol-3-yl)(<span class="italic">p</span>-tolyl)methanone (<strong>4k</strong>). </span><span>Product <strong>4k</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>) using 2-(pyridin-2-yl)-2<span class="italic">H</span>-indazole <strong>1l</strong> (98 mg, 0.5 mmol) and 4-methylbenzaldehyde <strong>2b</strong> (118 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 82% yield (131 mg, 0.42 mmol); mp: 98–100 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.33; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 8.25–8.23 (m, 1H), 8.06–8.04 (m, 1H), 7.89–7.82 (m, 2H), 7.77 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 7.46 (d, <span class="italic">J</span> = 8.8 Hz, 1H), 7.40–7.35 (m, 1H), 7.23–7.21 (m 3H), 7.16–7.12 (m, 1H), 2.40 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 186.81, 151.87, 149.01, 148.04, 144.29, 138.64, 135.30, 132.73, 129.78, 129.30, 127.74, 124.47, 123.50, 123.28, 120.62, 118.35, 117.33, 21.76; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>20</sub></small>H<small><sub>15</sub></small>N<small><sub>3</sub></small>O, 31.1288 [M + H]<small><sup>+</sup></small>; found, 314.1286.</span></div>
<div><span id="sect1936"/><span class="c_heading_indent">Phenyl(2-phenyl-2<span class="italic">H</span>-indazol-3-yl)methanone (<strong>4l</strong>). </span><span><strong>P</strong>roduct <strong>4l</strong> was obtained by utilizing the general procedure (<a title="Select to navigate to scheme" href="#imgsch3">Scheme 3</a>) using 2-phenyl-2<span class="italic">H</span>-indazole <strong>1m</strong> (97 mg, 0.5 mmol) and benzaldehyde <strong>2a</strong> (118 μL, 1 mmol) and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a yellow solid in 80% yield (119 mg, 0.40 mmol); mp: 125–127 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.42; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.89–7.85 (m, 3H), 7.62–7.57 (m, 1H), 7.55–7.52 (m, 2H), 7.47–7.35 (m, 7H), 7.19–7.15 (m, 1H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 186.07, 148.66, 140.58, 137.90, 133.67, 132.35, 130.00, 129.18, 129.03, 128.74, 127.12, 125.63, 125.12, 124.16, 120.68, 118.63; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>20</sub></small>H<small><sub>14</sub></small>N<small><sub>2</sub></small>O, 299.1179 [M + H]<small><sup>+</sup></small>; found, 299.1176.</span></div>

<h3 id="sect1961"><span class="b_heading">General procedure for the synthesis of <strong>11</strong></span></h3>
<span>The starting substrate <strong>1p</strong> was synthesized using the reported procedure<a title="Select to navigate to references" href="#cit15"><sup><span class="sup_ref">15</span></sup></a> and was reacted with <span class="italic">m</span>-acetoxybenzaldehyde <strong>2r</strong> under the optimized reaction conditions to afford <strong>10</strong>. In the reaction vessel, 2-(3-methoxyphenyl)-2<span class="italic">H</span>-indazole (<strong>1p</strong>, 112 mg, 0.5 mmol) was charged with <span class="italic">m</span>-acetoxybenzaldehyde (<strong>2r</strong>, 164 mg, 1 mmol) and TBPB (238 μL, 1.25 mmol) dissolved in chlorobenzene. The reaction mixture was then stirred under N<small><sub>2</sub></small> atmosphere at 110 °C for 24 h. After completion of the reaction, the reaction mixture was cooled and the work-up was done with a saturated solution of NaHCO<small><sub>3</sub></small> (10 mL) and ethyl acetate (3 × 20 mL). The combined organic layers were dried over anhydrous Na<small><sub>2</sub></small>SO<small><sub>4</sub></small>, filtered, and concentrated under reduced pressure to get the crude residue which was further purified through column chromatography on silica gel (100–200 mesh) using hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>ethyl acetate (95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>5 ratio) as an eluent to afford the corresponding product <strong>10</strong> which upon deprotection under basic conditions furnished the desire product <strong>11</strong> (anti-inflammatory agent).</span>
<div><span id="sect1980"/><span class="c_heading_indent">(3-Hydroxyphenyl)(2-(3-methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)methanone (<strong>11</strong>). </span><span>Product <strong>11</strong> was obtained by utilizing the general procedure and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>05) as a white solid in 51% yield (87 mg, 0.25 mmol); <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOAc = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15): 0.20; <small><sup>1</sup></small>H NMR (400 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 9.84 (s, 1H), 7.84 (d, <span class="italic">J</span> = 8.8 Hz, 1H), 7.40–7.17 (m, 6H), 7.13 (t, <span class="italic">J</span> = 2.4 Hz, 1H), 7.11–7.09 (m, 1H), 7.04–6.96 (m, 3H), 3.72 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, DMSO-<span class="italic">d</span><small><sub>6</sub></small>) <span class="italic">δ</span> 186.09, 160.00, 158.10, 148.30, 141.66, 139.09, 132.77, 130.49, 127.70, 125.58, 123.85, 121.48, 121.08, 120.75, 118.74, 118.22, 116.01, 115.27, 111.66, 56.02; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>21</sub></small>H<small><sub>16</sub></small>N<small><sub>2</sub></small>O<small><sub>3</sub></small>, 345.1234 [M + H]<small><sup>+</sup></small>; found, 345.1236.</span></div>

<h3 id="sect2005"><span class="b_heading">General procedure for the synthesis of <strong>13</strong></span></h3>
<span>The starting material <strong>12</strong> was synthesized by utilizing our general procedure which on subjection to Pd-catalyzed direct biaryl coupling using the reported procedure<a title="Select to navigate to references" href="#cit16"><sup><span class="sup_ref">16</span></sup></a> afforded a new class of bio-azaheterocycles, <span class="italic">i.e.</span>, 3-methoxy-9<span class="italic">H</span>-dibenzo[4,5:6,7]azepino[1,2-<span class="italic">b</span>]indazol-9-one (indazole-fused diazepine).</span>
<div><span id="sect2014"/><span class="c_heading_indent">3-Methoxy-9<span class="italic">H</span>-dibenzo[4,5:6,7]azepino[1,2-<span class="italic">b</span>]indazol-9-one (<strong>13</strong>). </span><span>Product <strong>13</strong> was obtained by utilizing the general procedure and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>DCM = 90<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>10) as a yellow solid in 75% yield (123 mg, 0.37 mmol); mp: 108–110 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>DCM = 50<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>50): 0.5; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 8.14–8.09 (m, 2H), 8.05–8.03 (m, 1H), 7.82 (d, <span class="italic">J</span> = 8.8 Hz, 1H), 7.77 (d, <span class="italic">J</span> = 7.6 Hz, 1H), 7.66–7.62 (m, 1H), 7.55–7.51 (m, 1H), 7.41–7.37 (m, 1H), 7.31–7.27 (m, 1H), 7.19 (d, <span class="italic">J</span> = 2.8 Hz, 1H), 7.09 (dd, <span class="italic">J</span> = 9.2, 2.8 Hz, 1H), 3.89 (s, 3H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 183.27, 159.12, 148.62, 139.52, 138.11, 134.80, 132.75, 131.61, 130.70, 130.17, 129.16, 128.72, 127.93, 127.60, 125.89, 123.69, 121.09, 118.05, 116.36, 115.47, 55.84; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>21</sub></small>H<small><sub>14</sub></small>N<small><sub>2</sub></small>O<small><sub>2</sub></small>, 327.1128 [M + H]<small><sup>+</sup></small>; found, 327.1126.</span></div>

<h3 id="sect2040"><span class="b_heading">General procedure for the synthesis of <strong>14</strong></span></h3>
<span>To a solution of <strong>3a</strong> (0.29 mmol; 1.0 equiv.) in methanol (10–15 mL) was added NaBH<small><sub>4</sub></small> (0.58 mmol; 2.0 equiv.) portionwise at room temperature and the reaction was stirred at the same temperature for 1 h. After completion of the reaction monitored by TLC, the solvent was evaporated under reduced pressure and the crude solid product was extracted with ethyl acetate (3 × 20 mL) and water (10 mL). The combined organic layers were dried over anhydrous Na<small><sub>2</sub></small>SO<small><sub>4</sub></small>, filtered, and concentrated under reduced pressure to get the crude residue which was further purified through column chromatography on silica gel (100–200 mesh) using hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>ethyl acetate (80<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>20 ratio) as an eluent to afford the corresponding product <strong>14</strong> as a white solid in 90% yield.</span>
<div><span id="sect2049"/><span class="c_heading_indent">(2-(4-Methoxyphenyl)-2<span class="italic">H</span>-indazol-3-yl)(<span class="italic">p</span>-tolyl)methanol (<strong>14</strong>). </span><span>Product <strong>14</strong> was obtained by utilizing the general procedure and isolated by column chromatography (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOH = 80<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>20) as a white solid in 90% yield (90 mg, 0.26 mmol); mp: 106–108 °C; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>EtOH = 70<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>30): 0.3; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.51 (d, <span class="italic">J</span> = 9.2 Hz, 1H), 7.39 (d, <span class="italic">J</span> = 9.2 Hz, 1H), 7.15–7.09 (m, 3H), 7.04 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 6.98 (d, <span class="italic">J</span> = 8.0 Hz, 2H), 6.87–6.83 (m, 1H), 6.69 (d, <span class="italic">J</span> = 8.8 Hz, 2H), 5.93 (s, 1H), 3.69 (s, 3H), 2.22 (s, 3H); <small><sup>13</sup></small>C NMR (101 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 159.98, 148.56, 138.37, 137.65, 137.54, 132.49, 129.26, 127.48, 126.69, 126.47, 121.84, 121.40, 120.39, 117.40, 114.16, 68.75, 55.62, 21.25; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>22</sub></small>H<small><sub>20</sub></small>N<small><sub>2</sub></small>O<small><sub>2</sub></small>, 345.1598 [M + H]<small><sup>+</sup></small>; found, 345.1596.</span></div>

<h3 id="sect2076"><span class="b_heading">General procedure for the competition reaction</span></h3>
<span>A mixture of 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol), 4-methoxybenzaldehyde <strong>2c</strong> (61 μL, 0.5 mmol) and 4-fluorobenzaldehyde <strong>2e</strong> (53 μL, 0.5 mmol) and TBPB (238 μL, 1.25 mmol) was taken in a sealed reaction tube under nitrogen atmosphere. Then, the reaction mixture was stirred at 110 °C for 24 h. After completion of the reaction, the reaction mixture was cooled and the work-up was done with a saturated solution of NaHCO<small><sub>3</sub></small> (10 mL) and ethyl acetate (3 × 20 mL). The combined organic layers were dried over anhydrous Na<small><sub>2</sub></small>SO<small><sub>4</sub></small>, filtered, and concentrated under reduced pressure to get the crude residue which was further purified through column chromatography on silica gel (100–200 mesh) using hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>ethyl acetate (95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>5 ratio) as an eluent to afford the corresponding product <strong>3c</strong> in 56% (101 mg, 0.28 mmol as a yellow solid) and <strong>3e</strong> in 30% (52 mg, 0.15 mmol as a yellow solid) yields, respectively. Similarly, a mixture of 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol), 4-methylbenzaldehyde <strong>2a</strong> (59 μL, 0.5 mmol) and acetaldehyde <strong>2j</strong> (28 μL, 0.5 mmol) and TBPB (238 μL, 1.25 mmol) was taken in a sealed reaction tube under nitrogen atmosphere. Then the reaction mixture was stirred at 110 °C for 24 h. After work-up, the crude residue was further purified through column chromatography on silica gel (100–200 mesh) using hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>ethyl acetate (95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>5 ratio) as an eluent to afford the corresponding product <strong>3a</strong> in 55% (94 mg, 0.27 mmol as a yellow solid) and <strong>3j</strong> in 29% (39 mg, 0.14 mmol as a yellow solid) yields, respectively.</span>

<h3 id="sect2094"><span class="b_heading">Synthetic procedure for performing the control experiment</span></h3>
<span>A mixture of 2-(4-methoxyphenyl)-2<span class="italic">H</span>-indazole <strong>1a</strong> (112 mg, 0.5 mmol), 4-methylbenzaldehyde <strong>2a</strong> (118 μL, 1 mmol) and TBPB (238 μL, 1.25 mmol) and TEMPO (195 mg, 1.25 mmol) was taken in a sealed reaction tube under nitrogen atmosphere. Then, the reaction mixture was stirred at 110 °C for 24 h. After completion of the reaction, the reaction mixture was cooled and the work-up was done with a saturated solution of NaHCO<small><sub>3</sub></small> (10 mL) and ethyl acetate (3 × 20 mL). The combined organic layers were dried over anhydrous Na<small><sub>2</sub></small>SO<small><sub>4</sub></small>, filtered, and concentrated under reduced pressure to get the crude residue which was further purified through column chromatography on silica gel (100–200 mesh) using hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>ethyl acetate (95<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>5 ratio) as an eluent to afford the TEMPO trapped acyl adduct (<strong>7</strong>) as a viscous liquid. TLC observation showed that there was no formation of <strong>3a</strong> in the TEMPO-assisted reaction. The intermediate, <span class="italic">i.e.</span> benzoyl free radical, was trapped with TEMPO to afford the TEMPO-acyl adduct <strong>7</strong>.</span>
<div><span id="sect2107"/><span class="c_heading_indent">2,2,6,6-Tetramethylpiperidin-1-yl 4-methylbenzo-ate <strong>7</strong>. </span><span>Product <strong>7</strong> was obtained in 71% yield as a viscous liquid; <span class="italic">R</span><small><sub>f</sub></small> (hexane<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>ethyl acetate = 85<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>15) 0.5; <small><sup>1</sup></small>H NMR (400 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 7.93 (d, <span class="italic">J</span> = 8.4 Hz, 2H), 7.21 (d, <span class="italic">J</span> = 8.0 Hz, 2H), 2.37 (s, 3H), 1.77–1.63 (m, 3H), 1.55–1.52 (m, 2H), 1.43–1.40 (m, 1H), 1.23 (s, 6H), 1.08 (s, 6H); <small><sup>13</sup></small>C NMR (100 MHz, chloroform-<span class="italic">d</span>) <span class="italic">δ</span> 166.50, 143.56, 129.66, 129.22, 128.52, 126.98, 60.40, 39.11, 32.03, 25.43, 21.72, 20.91, 17.08; HRMS (ESI/QTOF) <span class="italic">m</span>/<span class="italic">z</span>: calcd for C<small><sub>17</sub></small>H<small><sub>25</sub></small>NO<small><sub>2</sub></small>, 276.1958 [M + H]<small><sup>+</sup></small>; found, 276.1955.</span></div>


<h2 id="sect2128"><span class="a_heading">Conflicts of interest</span></h2>
<span>The author declares no competing financial interest.</span>


<h2 id="sect2132"><span class="a_heading">Acknowledgements</span></h2><span>S. C. acknowledges DST-NRF Indo-South Africa Joint research project [DST/INT/South Africa/P-19/2016]. R. S. acknowledges MNIT Jaipur for providing an institute fellowship. L. Y. and R. K. Y. thanks DST, New Delhi and UGC, New Delhi for providing financial assistance in the form of a senior research fellowship. Materials Research Centre (MRC), MNIT Jaipur is gratefully acknowledged for providing analytical facilities.</span>
<span id="sect2134"><h2 id="sect2131"><span class="a_heading">Notes and references</span></h2></span><ol type="1"><li><span id="cit1">
  (<i>&#97;</i>) <span id="cit1a">C.-Y. Huang, H. Kang, J. Li and C.-J. Li, <span class="italic">J. Org. Chem.</span>, 2019, <span class="bold">84</span>, 12705–12721 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.joc.9b01704" title="DOI Link to resource 10.1021/acs.joc.9b01704">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXhs1egu7bL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31441304%5Buid%5D" title="PubMed Link to resource 31441304">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit1b">S. Girard, T. Knauber and C. -J. Li, <span class="italic">Angew. Chem., Int. Ed.</span>, 2014, <span class="bold">53</span>, 74–100 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201304268" title="DOI Link to resource 10.1002/anie.201304268">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhslCqsL3J" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24214829%5Buid%5D" title="PubMed Link to resource 24214829">PubMed</a></span>; 
  (<i>&#99;</i>) <span id="cit1c">C.-J. Li, <span class="italic">Acc. Chem. Res.</span>, 2009, <span class="bold">42</span>, 335–344 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ar800164n" title="DOI Link to resource 10.1021/ar800164n">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhsFSit7vI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19220064%5Buid%5D" title="PubMed Link to resource 19220064">PubMed</a></span>.</span></li><li><span id="cit2">
  (<i>&#97;</i>) <span id="cit2a">C. N. Sternberg, I. D. Davis, J. Mardiak, C. Szczylik, E. Lee, J. Wagstaff, C. H. Barrios, P. Salman, O. A. Gladkov, A. Kavina, J. J. Zarbá, M. Chen, L. McCann, L. Pandite, D. F. Roychowdhury and R. E. Hawkins, <span class="italic">J. Clin. Oncol.</span>, 2010, <span class="bold">28</span>, 1061–1068 <a target="_blank" class="DOILink" href="https://doi.org/10.1200/JCO.2009.23.9764" title="DOI Link to resource 10.1200/JCO.2009.23.9764">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXktF2lt78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20100962%5Buid%5D" title="PubMed Link to resource 20100962">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit2b">P. Jones, S. Altamura, J. Boueres, F. Ferrigno, M. Fonsi, C. Giomini, S. Lamartina, E. Monteagudo, J. M. Ontoria, M. V. Orsale, M. C. Palumbi, S. Pesci, G. Roscilli, R. Scarpelli, C. Schultz- Fademrecht, C. Toniatti and M. Rowley, <span class="italic">J. Med. Chem.</span>, 2009, <span class="bold">52</span>, 7170–7185 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jm901188v" title="DOI Link to resource 10.1021/jm901188v">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXhtleisLjM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19873981%5Buid%5D" title="PubMed Link to resource 19873981">PubMed</a></span>; 
  (<i>&#99;</i>) <span id="cit2c">A. Floridi, M. G. Paggi, M. L. Marcante, B. Silvestrini, A. Caputo and C. D. Martino, <span class="italic">J. Natl. Cancer Inst.</span>, 1981, <span class="bold">66</span>, 497 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaL3MXhsFSit70%253D" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#100;</i>) <span id="cit2d">H. Shen, S. Gou, J. Shen, Y. Zhu, Y. Zhang and X. Chen, <span class="italic">Bioorg. Med. Chem. Lett.</span>, 2010, <span class="bold">20</span>, 2115 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.bmcl.2010.02.061" title="DOI Link to resource 10.1016/j.bmcl.2010.02.061">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXjslGmsb0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20223660%5Buid%5D" title="PubMed Link to resource 20223660">PubMed</a></span>; 
  (<i>&#101;</i>) <span id="cit2e">L. A. Clutterbuck, C. G. Posada, C. Visintin, D. R. Riddal, B. Lancaster, P. J. Gane, J. Garthwaite and D. L. Selwood, <span class="italic">J. Med. Chem.</span>, 2009, <span class="bold">52</span>, 2694 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jm801180p" title="DOI Link to resource 10.1021/jm801180p">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXjvF2gsrs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19341281%5Buid%5D" title="PubMed Link to resource 19341281">PubMed</a></span>; 
  (<i>&#102;</i>) <span id="cit2f">D. Szymon, B. Marta, P. Arkadiusz, P. Michał, F. Michał, W. Maria, D. Anna, S. Sebastian, T. Adam and K. Marcin, <span class="italic">Int. J. Cardiol.</span>, 2018, <span class="bold">269</span>, 283 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ijcard.2018.07.015" title="DOI Link to resource 10.1016/j.ijcard.2018.07.015">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30017517%5Buid%5D" title="PubMed Link to resource 30017517">PubMed</a></span>; 
  (<i>&#103;</i>) <span id="cit2g">M. C. Vega, M. Rolón, A. Montero-Torres, C. Fonseca-Berzal, J. A. Escario, A. Gómez-Barrio, J. Gálvez, Y. Marrero-Ponce and V. J. Arán, <span class="italic">Eur. J. Med. Chem.</span>, 2012, <span class="bold">58</span>, 214 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ejmech.2012.10.009" title="DOI Link to resource 10.1016/j.ejmech.2012.10.009">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XhslOrsr3E" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23124218%5Buid%5D" title="PubMed Link to resource 23124218">PubMed</a></span>; 
  (<i>&#104;</i>) <span id="cit2h">A. Tanitame, Y. Oyamada, K. Ofuji, Y. Kyoya, K. Suzuki, H. Ito, M. Kawasaki, K. Nagai, M. Wachi and J. Yamagishi, <span class="italic">Bioorg. Med. Chem. Lett.</span>, 2004, <span class="bold">14</span>, 2857 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.bmcl.2004.03.044" title="DOI Link to resource 10.1016/j.bmcl.2004.03.044">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2cXjs1amtbo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15125947%5Buid%5D" title="PubMed Link to resource 15125947">PubMed</a></span>; 
  (<i>&#105;</i>) <span id="cit2i">W. Han, J. C. Pelletier and C. N. Hodge, <span class="italic">Bioorg. Med. Chem. Lett.</span>, 1998, <span class="bold">8</span>, 3615 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0960-894X(98)00659-3" title="DOI Link to resource 10.1016/S0960-894X(98)00659-3">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK1MXltVKnuw%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=9934481%5Buid%5D" title="PubMed Link to resource 9934481">PubMed</a></span>.</span></li><li><span id="cit3">
  (<i>&#97;</i>) <span id="cit3a">A. Thangadurai, M. Minu, S. Wakode, S. Agrawal and B. Narasimhan, <span class="italic">Med. Chem. Res.</span>, 2012, <span class="bold">21</span>, 1509 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s00044-011-9631-3" title="DOI Link to resource 10.1007/s00044-011-9631-3">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXksFWgt7g%253D" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#98;</i>) <span id="cit3b">I. Denya, S. F. Malan and J. Joubert, <span class="italic">Expert Opin. Ther. Pat.</span>, 2018, <span class="bold">28</span>, 441 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/13543776.2018.1472240" title="DOI Link to resource 10.1080/13543776.2018.1472240">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXptlSjt7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29718740%5Buid%5D" title="PubMed Link to resource 29718740">PubMed</a></span>; 
  (<i>&#99;</i>) <span id="cit3c">H. Cerecetto, A. Gerpe, M. Gonzalez, V. Aran and C. de Ocariz, <span class="italic">Mini-Rev. Med. Chem.</span>, 2005, <span class="bold">5</span>, 869 <a target="_blank" class="DOILink" href="https://doi.org/10.2174/138955705774329564" title="DOI Link to resource 10.2174/138955705774329564">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWku73K" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16250831%5Buid%5D" title="PubMed Link to resource 16250831">PubMed</a></span>; 
  (<i>&#100;</i>) <span id="cit3d">J. Dong, Q. Zhang, Z. Wang, G. Huang and S. Li, <span class="italic">ChemMedChem</span>, 2018, <span class="bold">13</span>, 1490 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/cmdc.201800253" title="DOI Link to resource 10.1002/cmdc.201800253">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhtF2lurfE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29863292%5Buid%5D" title="PubMed Link to resource 29863292">PubMed</a></span>; 
  (<i>&#101;</i>) <span id="cit3e">F.-Y. Lee, J.-C. Lien, L.-J. Huang, T.-M. Huang, S.-C. Tsai, C.-M. Teng, C.-C. Wu, F.-C. Cheng and S.-C. Kuo, <span class="italic">J. Med. Chem.</span>, 2001, <span class="bold">44</span>, 3746 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jm010001h" title="DOI Link to resource 10.1021/jm010001h">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3MXntVyntLs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11606139%5Buid%5D" title="PubMed Link to resource 11606139">PubMed</a></span>; 
  (<i>&#102;</i>) <span id="cit3f">Y. Ikeda, N. Takano, H. Matsushita, Y. Shiraki, T. Koide, R. Nagashima, Y. Fujimura, M. Shindo, S. Suzuki and T. Iwasaki, <span class="italic">Arzneim. Forsch.</span>, 1979, <span class="bold">29</span>, 511 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaE1MXktVShtLk%253D" title="Link to resource in CAS">CAS</a></span>; 
  (<i>&#103;</i>) <span id="cit3g">S.-G. Zhang, C.-G. Liang and W.-H. Zhang, <span class="italic">Molecules</span>, 2018, <span class="bold">23</span>, 2783 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/molecules23112783" title="DOI Link to resource 10.3390/molecules23112783">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30373212%5Buid%5D" title="PubMed Link to resource 30373212">PubMed</a></span>.</span></li><li><span id="cit4">
  (<i>&#97;</i>) <span id="cit4a">L. Yadav and S. Chaudhary, <span class="italic">Org. Biomol. Chem.</span>, 2020, <span class="bold">18</span>, 5927–5936 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D0OB01282C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D0OB01282C">RSC</a></span>; 
  (<i>&#98;</i>) <span id="cit4b">S. Ghosh, S. Mondal and A. Hajra, <span class="italic">Adv. Synth. Catal.</span>, 2020, <span class="bold">362</span>, 3768–3794 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adsc.202000423" title="DOI Link to resource 10.1002/adsc.202000423">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhtl2isb%252FN" title="Link to resource in CAS">CAS</a></span>.</span></li><li><span id="cit5">H. Oh, S. Han, A. K. Pandey, S. H. Han, N. K. Mishra, S. Kim, R. Chun, H. S. Kim, J. Park and I. S. Kim, <span class="italic">J. Org. Chem.</span>, 2018, <span class="bold">83</span>, 4070–4077 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.joc.8b00501" title="DOI Link to resource 10.1021/acs.joc.8b00501">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXkslWmt78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29547287%5Buid%5D" title="PubMed Link to resource 29547287">PubMed</a>.</span></li><li><span id="cit6">G. Bogonda, H. Y. Kim and K. Oh, <span class="italic">Org. Lett.</span>, 2018, <span class="bold">9</span>, 2711–2715 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.8b00920" title="DOI Link to resource 10.1021/acs.orglett.8b00920">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29672060%5Buid%5D" title="PubMed Link to resource 29672060">PubMed</a>.</span></li><li><span id="cit7">Y.-L. Liu, Y.-L. Pan, G.-J. Li, H.-F. Xu and J.-Z. Chen, <span class="italic">Org. Biomol. Chem.</span>, 2019, <span class="bold">17</span>, 8749–8755 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C9OB01749F&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C9OB01749F">RSC</a>.</span></li><li><span id="cit8">L. Liu, P. Jiang, Y. Liu, H. Du and J. Tan, <span class="italic">Org. Chem. Front.</span>, 2020, <span class="bold">7</span>, 2278–2283 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D0QO00507J&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D0QO00507J">RSC</a>.</span></li><li><span id="cit9">
  (<i>&#97;</i>) <span id="cit9a">R. Chen, J. Chen, J. Zhang and X. Wan, <span class="italic">Chem. Rec.</span>, 2018, <span class="bold">18</span>, 1292 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/tcr.201700069" title="DOI Link to resource 10.1002/tcr.201700069">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXjvVygtbo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29513383%5Buid%5D" title="PubMed Link to resource 29513383">PubMed</a></span>; 
  (<i>&#98;</i>) <span id="cit9b">S. Rajamanickam, G. Majji, S. K. Santra and B. K. Patel, <span class="italic">Org. Lett.</span>, 2015, <span class="bold">17</span>, 5586 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.orglett.5b02749" title="DOI Link to resource 10.1021/acs.orglett.5b02749">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhslGms77K" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26528788%5Buid%5D" title="PubMed Link to resource 26528788">PubMed</a></span>; 
  (<i>&#99;</i>) <span id="cit9c">G. Majji, S. Rajamanickam, N. Khatun, S. K. Santra and B. K. Patel, <span class="italic">J. Org. Chem.</span>, 2015, <span class="bold">80</span>, 3440 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jo502903d" title="DOI Link to resource 10.1021/jo502903d">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXktFanuro%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25761246%5Buid%5D" title="PubMed Link to resource 25761246">PubMed</a></span>; 
  (<i>&#100;</i>) <span id="cit9d">A. Gogoi, A. Modi, S. Guin, S. K. Rout, D. Das and B. K. Patel, <span class="italic">Chem. Commun.</span>, 2014, <span class="bold">50</span>, 10445 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C4CC04407J&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C4CC04407J">RSC</a></span>; 
  (<i>&#101;</i>) <span id="cit9e">X.-F. Wu, J.-L. Gonga and X. Qia, <span class="italic">Org. Biomol. Chem.</span>, 2014, <span class="bold">12</span>, 5807 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C4OB00276H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C4OB00276H">RSC</a></span>; 
  (<i>&#102;</i>) <span id="cit9f">Y. Siddaraju and K. R. Prabhu, <span class="italic">Tetrahedron</span>, 2016, <span class="bold">72</span>, 959–967 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.tet.2015.12.065" title="DOI Link to resource 10.1016/j.tet.2015.12.065">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xot1Crtg%253D%253D" title="Link to resource in CAS">CAS</a></span>.</span></li><li><span id="cit10">
  (<i>&#97;</i>) <span id="cit10a">N. Khatun, A. Banerjee, S. K. Santra, A. Behera and B. K. Patel, <span class="italic">RSC Adv.</span>, 2014, <span class="bold">4</span>, 54532 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C4RA11014E&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C4RA11014E">RSC</a></span>; 
  (<i>&#98;</i>) <span id="cit10b">S. K. Rout, S. Guin, A. Gogoi, G. Majji and B. K. Patel, <span class="italic">Org. Lett.</span>, 2014, <span class="bold">16</span>, 1614 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol500224e" title="DOI Link to resource 10.1021/ol500224e">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXjsVehtr8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24588713%5Buid%5D" title="PubMed Link to resource 24588713">PubMed</a></span>.</span></li><li><span id="cit11">
  (<i>&#97;</i>) <span id="cit11a">J.-J. Cao, T.-H. Zhu, S.-Y. Wang, Z.-Y. Gu, X. Wang and S.-J. Ji, <span class="italic">Chem. Commun.</span>, 2014, <span class="bold">50</span>, 6439–6442 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C4CC00743C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C4CC00743C">RSC</a></span>; 
  (<i>&#98;</i>) <span id="cit11b">S.-L. Zhou, L.-N. Guo, H. Wang and X.-H. Duan, <span class="italic">Chem.–Eur. J.</span>, 2013, <span class="bold">19</span>, 12970–12973 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/chem.201302139" title="DOI Link to resource 10.1002/chem.201302139">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhtlyrs7zF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24038342%5Buid%5D" title="PubMed Link to resource 24038342">PubMed</a></span>; 
  (<i>&#99;</i>) <span id="cit11c">T. He, H. Li, P. Li and L. Wang, <span class="italic">Chem. Commun.</span>, 2011, <span class="bold">47</span>, 8946–8948 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C1CC13086B&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C1CC13086B">RSC</a></span>; 
  (<i>&#100;</i>) <span id="cit11d">H. Zhang, Z. Gu, P. Xu, H. Hu, Y. Chenga and C. Zhu, <span class="italic">Chem. Commun.</span>, 2016, <span class="bold">52</span>, 477–480 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5CC07175E&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5CC07175E">RSC</a></span>.</span></li><li><span id="cit12">R. J. Steffan, E. M. Matelan, [(1<span class="italic">H</span>-Indazol-3-ly)Methyl]Phenols and (Hydroxyphenyl), (1<span class="italic">H</span>-Indazol-3-yl)Methanones, <span class="italic">WO Pat.</span>, 2006050006,  2006.</span></li><li><span id="cit13">A. H. Shinde, S. Vidyacharan and D. S. Sharada, <span class="italic">Org. Biomol. Chem.</span>, 2016, <span class="bold">14</span>, 3207–3211 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C6OB00253F&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C6OB00253F">RSC</a>.</span></li><li><span id="cit14">M. R. Kumar, A. Park, N. Park and S. Lee, <span class="italic">Org. Lett.</span>, 2011, <span class="bold">13</span>, 3542–3545 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol201409j" title="DOI Link to resource 10.1021/ol201409j">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXntVemsrw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21644532%5Buid%5D" title="PubMed Link to resource 21644532">PubMed</a>.</span></li><li><span id="cit15">N. E. Genung, L. Wei and G. E. Aspnes, <span class="italic">Org. Lett.</span>, 2014, <span class="bold">16</span>, 3114–3117 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ol5012423" title="DOI Link to resource 10.1021/ol5012423">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXosVOgu7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24848311%5Buid%5D" title="PubMed Link to resource 24848311">PubMed</a>.</span></li><li><span id="cit16">A. P. Kozikowski and D. Ma, <span class="italic">Tetrahedron Lett.</span>, 1991, <span class="bold">32</span>, 3317–3320 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0040-4039(00)92695-9" title="DOI Link to resource 10.1016/S0040-4039(00)92695-9">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK3MXltlGrtLY%253D" title="Link to resource in CAS">CAS</a>.</span></li></ol>




<hr/><table><tr><td><h3>Footnote</h3></td></tr><tr><td><span class="sup_ref">† <span id="fn1">Electronic supplementary information (ESI) available: Characterization data, <small><sup>1</sup></small>H NMR and <small><sup>13</sup></small>C NMR spectra. See DOI: <a href="http://xlink.rsc.org/?DOI=d1ra02225c" target="_blank" title="Select to resolve DOI: 10.1039/d1ra02225c">10.1039/d1ra02225c</a></span></span></td></tr></table><table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry 2021</b></td></tr></table></div></div></div></body><script src="/content/scripts/CrossMarkIE.js"> </script><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>